Pasar al contenido principal

METODOS Y APLICACIONES DE APRENDIZAJE PROFUNDO Y SUPERFICIAL DE FENOTIPOS PARA ANALISIS Y PREDICCION DE DATOS BIOMEDICOS.

PID2021-122952OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT POLITECNICA DE CATALUNYA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 36
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Artificial intelligence, a new field of knowledge for nephrologists

  • Fayos de Arizón, Leonor|||0000-0002-9277-645X
  • R. Viera, Elizabeth
  • Pilco-Teran, Melissa|||0000-0002-1311-0896
  • Perera Lluna, Alexandre|||0000-0001-6427-851X
  • De Maeztu, Gabriel
  • Nicolau, Anna
  • Furlano, Monica|||0000-0003-1025-3901
  • Torra Balcells, Roser|||0000-0001-8714-2332
Artificial intelligence (AI) is a science that involves creating machines that can imitate human intelligence and learn. AI is ubiquitous in our daily lives, from search engines like Google to home assistants like Alexa and, more recently, OpenAI with its chatbot. AI can improve clinical care and research, but its use requires a solid understanding of its fundamentals, the promises and perils of algorithmic fairness, the barriers and solutions to its clinical implementation, and the pathways to developing an AI-competent workforce. The potential of AI in the field of nephrology is vast, particularly in the areas of diagnosis, treatment and prediction. One of the most significant advantages of AI is the ability to improve diagnostic accuracy. Machine learning algorithms can be trained to recognize patterns in patient data, including lab results, imaging and medical history, in order to identify early signs of kidney disease and thereby allow timely diagnoses and prompt initiation of treatment plans that can improve outcomes for patients. In short, AI holds the promise of advancing personalized medicine to new levels. While AI has tremendous potential, there are also significant challenges to its implementation, including data access and quality, data privacy and security, bias, trustworthiness, computing power, AI integration and legal issues. The European Commission's proposed regulatory framework for AI technology will play a significant role in ensuring the safe and ethical implementation of these technologies in the healthcare industry. Training nephrologists in the fundamentals of AI is imperative because traditionally, decision-making pertaining to the diagnosis, prognosis and treatment of renal patients has relied on ingrained practices, whereas AI serves as a powerful tool for swiftly and confidently synthesizing this information. plans, leading to better patient outcomes. However, the implementation of AI in healthcare faces several challenges. The European Commission's proposed regulatory framework aims to promote the safe and ethical use of AI in healthcare. To fully leverage the benefits of AI, nephrologists and other healthcare professionals need to be educated about its fundamentals and its potential applications in routine patient care. This will enable them to effectively utilize AI technologies and provide better care for kidney patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mediterranean Diet Is a Predictor of Progression of Subclinical Atherosclerosis in a Mediterranean Population, The ILERVAS Prospective Cohort Study

  • Rojo López, Marina Idalia|||0000-0001-6748-3156
  • Bermúdez-López, Marcelino|||0000-0002-3188-4158
  • Castro, Eva
  • Farràs-Sallés, Cristina|||0000-0001-5956-4116
  • Torres, Gerard|||0000-0002-1417-7320
  • Pamplona, Reinald|||0000-0003-4337-6107
  • Lecube, Albert|||0000-0001-9684-0183
  • Valdivieso, José Manuel
  • Fernández, Elvira|||0000-0001-5236-1762
  • Julve i Gil, Josep|||0000-0002-6531-2246
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
  • Antentas Peraile, María|||0009-0005-8140-203X
  • Barranco-Altirriba, Maria|||0000-0002-1525-210X
  • Perera Lluna, Alexandre|||0000-0001-6427-851X
  • Franch-Nadal, Josep|||0000-0002-5175-1555
  • Granado-Casas, Minerva|||0000-0003-3447-5728
  • Mauricio, Didac|||0000-0002-2868-0250
Atherosclerotic cardiovascular disease remains a major health issue, often developing silently as subclinical atherosclerotic disease (SAD). The Mediterranean diet (MDiet) is known for its cardiovascular benefits, but the combined influence of both MDiet adherence and physical activity (PA) on SAD progression has not been previously documented. Objective: We aimed to investigate how adherence to a healthy lifestyle, defined as MDiet adherence and PA level, influences SAD progression in subjects from the ILERVAS cohort follow-up. Methods: A study on 3097 participants from the ILERVAS prospective cohort was conducted. MDiet adherence was assessed using the MEDAS score, and PA categories were established using the IPAQ, both categorized into low, moderate, and high levels. Two different lifestyle scores integrating the MDiet and PA categories were built. The presence of atherosclerotic plaques was assessed by carotid and femoral ultrasound examination. Demographic, clinical, and biochemical data were also obtained. Multivariable linear, logistic, and Poisson regression models adjusted for potential confounders were used to analyze the association between the lifestyle scores and SAD progression, as well as the MDiet and PA as separate variables and number of territories with plaque. Results: A healthier lifestyle score did not show an effect on SAD progression. However, a higher MEDAS score was associated with a 3% decrease in the number of territories with plaque (IRR 0.97, 95% CI 0.96-0.99, p < 0.001), suggesting a protective effect of the adherence to the MDiet. PA did not show a significant association (IRR 1.00, 95% CI 1.00-1.00, p = 0.269). Older age, hypertension, dyslipidemia, smoking, and lower eGFR were associated with SAD progression, while the female sex was protective (IRR 0.67, 95% CI 0.63-0.72, p < 0.001). Conclusions: The findings of this study show that higher adherence to the MDiet is associated with reduced incidence of SAD, indicating its potential role in cardiovascular prevention strategies. Although a higher lifestyle score or physical activity levels did not show any significant effect, promoting the MDiet, alongside managing traditional cardiovascular risk factors, could be an effective public health intervention to prevent atherosclerosis and reduce the burden of cardiovascular disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Characterisation of type 2 diabetes subgroups at diagnosis, the COPERNICAN prospective observational cohort study protocol

  • Fernández-Camins, Berta|||0000-0001-7535-6181
  • Vlacho, Bogdan|||0000-0003-3768-8112
  • Canudas, Albert
  • Ortega, Marta
  • Granado-Casas, Minerva|||0000-0003-3447-5728
  • Perera Lluna, Alexandre|||0000-0001-6427-851X
  • Boluda-Sanson, Alejandro
  • El-Khattabi-Ofkir, Ysemina
  • Franch-Nadal, Josep|||0000-0002-5175-1555
  • Mauricio, Didac|||0000-0002-2868-0250
Introduction Type 2 diabetes mellitus (T2DM) is a highly heterogeneous and complex metabolic disease harbouring different metabolic characteristics. Adequate characterisation of subjects is essential to allow the implementation of precision medicine for the prevention, diagnosis, prognosis and treatment of this condition. Methods and analysis This prospective observational cohort study aims to identify and characterise relevant clinical clusters that are reproducibly associated with various clinical outcomes in T2DM in our Mediterranean region. The COPERNICAN study will include 1200 subjects with newly diagnosed T2DM from 28 primary care centres from the city of Barcelona and the healthcare district of Lleida in Catalonia (Spain). Participants will undergo a comprehensive phenotypic evaluation including, among others, six relevant variables: age, antibodies against glutamic acid decarboxylase, body mass index, glycated haemoglobin (HbA1c), indexes of insulin sensibility (HOMA2-IR) and secretion (HOMA2-beta). We will collect additional comprehensive data on glucose-lowering and other drug treatments, clinical evaluation (including complications), laboratory parameters, advanced lipoprotein profile, dietary habits and physical activity. The linkage with the population database will be done to perform a pragmatic follow-up of participants as part of their usual clinical care. A state-of-the-art cluster analysis (k-means and hierarchical clustering) will be performed. Ethics and dissemination The present study complies with all the ethical aspects and protection of participant subjects complying with all current local and European Union legislation. All Ethics Committees from the institutions involved in the study (IR Sant Pau Ethics Committee, Ethics Committee for Drug Research at IDIAP Jordi Gol and University Hospital of Bellvitge Ethics Committee for Research) approved this protocol. Confidentiality and anonymity of the data are ensured according to the current Spanish Organic Law 3/2018 of 05 December.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes

  • Barranco-Altirriba, Maria|||0000-0002-1525-210X
  • Rossell, Joana|||0000-0003-1500-6379
  • Alonso, N.
  • Weber, R.J.M.
  • Ortega, Emilio|||0000-0002-2217-8905
  • Lloyd, G.R.
  • Hernandez, Marta
  • Yanes, Oscar|||0000-0003-3695-7157
  • Capellades, Jordi|||0000-0002-6502-8202
  • Winder, Catherine|||0000-0002-1648-5255
  • Junza, Alexandra
  • Falguera, Mireia|||0000-0002-7846-8952
  • Franch-Nadal, Josep|||0000-0002-5175-1555
  • Dunn, Warwick B.|||0000-0001-6924-0027
  • Perera Lluna, Alexandre|||0000-0001-6427-851X
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Mauricio, Didac|||0000-0002-2868-0250
Background: Disruption of lipid metabolism contributes to increased cardiovascular risk in diabetes. Methods: We evaluated the associations between serum lipidomic profile and subclinical carotid atherosclerosis (SCA) in type 1 (T1D) and type 2 (T2D) diabetes, and in subjects without diabetes (controls) in a cross-sectional study. All subjects underwent a lipidomic analysis using ultra-high performance liquid chromatography-electrospray ionization tandem mass spectrometry, carotid ultrasound (mode B) to assess SCA, and clinical assessment. Multiple linear regression models were used to assess the association between features and the presence and burden of SCA in subjects with T1D, T2D, and controls separately. Additionally, multiple linear regression models with interaction terms were employed to determine features significantly associated with SCA within risk groups, including smoking habit, hypertension, dyslipidaemia, antiplatelet use and sex. Depending on the population under study, different confounding factors were considered and adjusted for, including sample origin, sex, age, hypertension, dyslipidaemia, body mass index, waist circumference, glycated haemoglobin, glucose levels, smoking habit, diabetes duration, antiplatelet use, and alanine aminotransferase levels. Results: A total of 513 subjects (151 T1D, 155 T2D, and 207 non-diabetic control) were included, in whom the percentage with SCA was 48.3%, 49.7%, and 46.9%, respectively. A total of 27 unique lipid species were associated with SCA in subjects with T2D, in former/current smokers with T2D, and in individuals with T2D without dyslipidaemia. Phosphatidylcholines and diacylglycerols were the main SCA-associated lipidic classes. Ten different species of phosphatidylcholines were up-regulated, while 4 phosphatidylcholines containing polyunsaturated fatty acids were down-regulated. One diacylglycerol was down-regulated, while the other 3 were positively associated with SCA in individuals with T2D without dyslipidaemia. We discovered several features significantly associated with SCA in individuals with T1D, but only one sterol could be partially annotated. Conclusions: We revealed a significant disruption of lipid metabolism associated with SCA in subjects with T2D, and a larger SCA-associated disruption in former/current smokers with T2D and individuals with T2D who do not undergo lipid-lowering treatment.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Mediterranean Diet Is a Predictor of Progression of Subclinical Atherosclerosis in a Mediterranean Population: The ILERVAS Prospective Cohort Study

  • Rojo López, Marina Idalia
  • Bermúdez López, Marcelino
  • Castro, Eva
  • Farràs, Cristina
  • Torres, Gerard
  • Pamplona Gras, Reinald
  • Lecube Torelló, Albert
  • Valdivieso, José Manuel
  • Fernández, Elvira
  • Julve, Josep
  • Castelblanco Echavarría, Esmeralda
  • Alonso, Núria
  • Antentas, Maria
  • Barranco Altirriba, María
  • Perera-Lluna, Alexandre
  • Franch-Nadal, Josep
  • Granado Casas, Minerva
  • Mauricio Puente, Dídac
  • ILERVAS Project Collaborators
Atherosclerotic cardiovascular disease remains a major health issue, often developing silently as subclinical atherosclerotic disease (SAD). The Mediterranean diet (MDiet) is known for its cardiovascular benefits, but the combined influence of both MDiet adherence and physical activity (PA) on SAD progression has not been previously documented. Objective: We aimed to investigate how adherence to a healthy lifestyle, defined as MDiet adherence and PA level, influences SAD progression in subjects from the ILERVAS cohort follow-up. Methods: A study on 3097 participants from the ILERVAS prospective cohort was conducted. MDiet adherence was assessed using the MEDAS score, and PA categories were established using the IPAQ, both categorized into low, moderate, and high levels. Two different lifestyle scores integrating the MDiet and PA categories were built. The presence of atherosclerotic plaques was assessed by carotid and femoral ultrasound examination. Demographic, clinical, and biochemical data were also obtained. Multivariable linear, logistic, and Poisson regression models adjusted for potential confounders were used to analyze the association between the lifestyle scores and SAD progression, as well as the MDiet and PA as separate variables and number of territories with plaque. Results: A healthier lifestyle score did not show an effect on SAD progression. However, a higher MEDAS score was associated with a 3% decrease in the number of territories with plaque (IRR 0.97, 95% CI 0.96–0.99, p < 0.001), suggesting a protective effect of the adherence to the MDiet. PA did not show a significant association (IRR 1.00, 95% CI 1.00–1.00, p = 0.269). Older age, hypertension, dyslipidemia, smoking, and lower eGFR were associated with SAD progression, while the female sex was protective (IRR 0.67, 95% CI 0.63–0.72, p < 0.001). Conclusions: The findings of this study show that higher adherence to the MDiet is associated with reduced incidence of SAD, indicating its potential role in cardiovascular prevention strategies. Although a higher lifestyle score or physical activity levels did not show any significant effect, promoting the MDiet, alongside managing traditional cardiovascular risk factors, could be an effective public health intervention to prevent atherosclerosis and reduce the burden of cardiovascular disease., This research was supported by the CIBER-Consorcio Centro de Investigación Biomédica en Red-(CB15/00071), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Spain. M.I.R.-L. holds a predoctoral grant SLT017/20/000107 from Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2021–2024 of Generalitat de Catalunya. JJ has received financial support from the Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033 and the European Union “NextGeneration EU”/PRTR) within the action “Consolidación Investigadora 2022” (CNS2022-135559) and Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Madrid, Spain), grant PI21/00770 (to J.J.), FEDER “Una manera de hacer Europa”. M Bermúdez-López holds a postdoctoral grant funded by the Ministerio de Ciencia, Innovación y Universidades (IJC2018-037792-I). This research was also funded by the Ministerio de Ciencia, Innovación y Universidades (grant PID2023-152233OBI00, co-funded by the European Regional Development Fund, “A way to build Europe”), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) and Department of Health (SLT002/16/00250) to R.P. This work was supported by grants from the Diputació de Lleida, Instituto de Salud Carlos III (RETIC RD16/0009/0011). This work was also supported by the Grant PID2021-122952OB-I00 funded by AEI 10.13039/501100011033 and by ERDF A way of making Europe; the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), initiatives of Instituto de Investigación Carlos III (ISCIII); ISCIII (grant AC22/00035); and the CERCA Programme/Generalitat de Catalunya. B2SLab is certified as 2021 SGR 01052. Institut d’Investigació Biomèdica Sant Pau and Biomedical Research Institute’s Dr. Pifarré Foundation from Lleida (IRBLleida) are accredited by the Generalitat de Catalunya as Centre de Recerca de Catalunya (CERCA).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes

  • Barranco-Altirriba, Maria
  • Rossell, Joana
  • Alonso, Núria
  • Weber, Ralf J.M.
  • Ortega, Emilio
  • Lloyd, Gavin R.
  • Hernández García, Marta
  • Yanes, Oscar
  • Capellades, Jordi
  • Winder, Catherine
  • Junza, Alexandra
  • Falguera, Mireia
  • Franch-Nadal, Josep
  • Dunn, Warwick B.
  • Perera-Lluna, Alexandre
  • Castelblanco Echavarría, Esmeralda
  • Mauricio Puente, Dídac
Background. Disruption of lipid metabolism contributes to increased cardiovascular risk in diabetes. Methods. We evaluated the associations between serum lipidomic profile and subclinical carotid atherosclerosis (SCA) in type 1 (T1D) and type 2 (T2D) diabetes, and in subjects without diabetes (controls) in a cross-sectional study. All subjects underwent a lipidomic analysis using ultra-high performance liquid chromatography–electrospray ionization tandem mass spectrometry, carotid ultrasound (mode B) to assess SCA, and clinical assessment. Multiple linear regression models were used to assess the association between features and the presence and burden of SCA in subjects with T1D, T2D, and controls separately. Additionally, multiple linear regression models with interaction terms were employed to determine features significantly associated with SCA within risk groups, including smoking habit, hypertension, dyslipidaemia, antiplatelet use and sex. Depending on the population under study, different confounding factors were considered and adjusted for, including sample origin, sex, age, hypertension, dyslipidaemia, body mass index, waist circumference, glycated haemoglobin, glucose levels, smoking habit, diabetes duration, antiplatelet use, and alanine aminotransferase levels. Results. A total of 513 subjects (151 T1D, 155 T2D, and 207 non-diabetic control) were included, in whom the percentage with SCA was 48.3%, 49.7%, and 46.9%, respectively. A total of 27 unique lipid species were associated with SCA in subjects with T2D, in former/current smokers with T2D, and in individuals with T2D without dyslipidaemia. Phosphatidylcholines and diacylglycerols were the main SCA-associated lipidic classes. Ten different species of phosphatidylcholines were up-regulated, while 4 phosphatidylcholines containing polyunsaturated fatty acids were down-regulated. One diacylglycerol was down-regulated, while the other 3 were positively associated with SCA in individuals with T2D without dyslipidaemia. We discovered several features significantly associated with SCA in individuals with T1D, but only one sterol could be partially annotated. Conclusions. We revealed a significant disruption of lipid metabolism associated with SCA in subjects with T2D, and a larger SCA-associated disruption in former/current smokers with T2D and individuals with T2D who do not undergo lipid-lowering treatment., This work was funded by Spanish Ministry of Health, Instituto de Salud Carlos III (Madrid, Spain) grants PI15/0625 (to DM and EC), PI17/01362 (to NA), PI18/0328 (to DM), FEDER “Una manera de hacer Europa”, and by Fundació La Marató de TV3 2016 (303/C/2016) (201602.30.31) (to NA). This work was supported by the Grant PID2021-122952OB-I00 funded by AEI h t t p s : / / d o i . o r g / 1 0 . 1 3 0 3 9 / 5 0 1 1 0 0 0 1 1 0 3 3 and by ERDF A way of making Europe (to AP). This research was supported by Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders (CIBERDEM–CB15/00071) (to DM) and Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), initiatives of Instituto de Investigación Carlos III (ISCIII); ISCIII (grant AC22/00035) (to AP); and the CERCA Programme / Generalitat de Catalunya. B2SLab is certified as 2021 SGR 01052. Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau is accredited by the Generalitat de Catalunya as Centre de Recerca de Catalunya (CERCA).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Characterisation of type 2 diabetes subgroups at diagnosis: the COPERNICAN prospective observational cohort study protocol

  • Fernandez Camins, Berta
  • Vlacho, Bogdan
  • Canudas Ventura, Albert
  • Ortega Bravo, Marta
  • Granado Casas, Minerva
  • Perera-Lluna, Alexandre
  • Boluda-Sanson, Alejandro
  • El-Khattabi-Ofkir, Yesmina
  • Franch-Nadal, Josep
  • Mauricio Puente, Dídac
Introduction Type 2 diabetes mellitus (T2DM) is a highly heterogeneous and complex metabolic disease harbouring different metabolic characteristics. Adequate characterisation of subjects is essential to allow the implementation of precision medicine for the prevention, diagnosis, prognosis and treatment of this condition. Methods and analysis This prospective observational cohort study aims to identify and characterise relevant clinical clusters that are reproducibly associated with various clinical outcomes in T2DM in our Mediterranean region. The COPERNICAN study will include 1200 subjects with newly diagnosed T2DM from 28 primary care centres from the city of Barcelona and the healthcare district of Lleida in Catalonia (Spain). Participants will undergo a comprehensive phenotypic evaluation including, among others, six relevant variables: age, antibodies against glutamic acid decarboxylase, body mass index, glycated haemoglobin (HbA1c), indexes of insulin sensibility (HOMA2-IR) and secretion (HOMA2-beta). We will collect additional comprehensive data on glucose-lowering and other drug treatments, clinical evaluation (including complications), laboratory parameters, advanced lipoprotein profile, dietary habits and physical activity. The linkage with the population database will be done to perform a pragmatic follow-up of participants as part of their usual clinical care. A state-of-the-art cluster analysis (k-means and hierarchical clustering) will be performed. Ethics and dissemination The present study complies with all the ethical aspects and protection of participant subjects complying with all current local and European Union legislation. All Ethics Committees from the institutions involved in the study (IR Sant Pau Ethics Committee, Ethics Committee for Drug Research at IDIAP Jordi Gol and University Hospital of Bellvitge Ethics Committee for Research) approved this protocol. Confidentiality and anonymity of the data are ensured according to the current Spanish Organic Law 3/2018 of 05 December. Trial registration number ClinicalTrials.gov. registration number NCT05333718, 27 January 2023., This research received financial support from the Spanish Ministry of Economy and Competitiveness (www.mineco.gob.es) PID2021-122952OB-I00, DPI2017-89827-R and Instituto de Salud Carlos III, Ministry of Health (PI21/01163). This work has been financed by a PERIS grant from the Primary Care Oriented Research Projects program with the reference number SLT021/21/000030 granted by the Generalitat de Catalunya (2022-2024). CIBER for Diabetes and Associated Metabolic Diseases (CIBERDEM; leading group CB15/00071) and the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), are initiatives of Instituto de Salud Carlos III (ISCIII)
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Lipidome characterisation and sex-specific differences in type 1 and type 2 diabetes mellitus

  • Barranco Altirriba, María
  • Alonso, Núria
  • Weber, Ralf J. M.
  • Lloyd, Gavin R.
  • Hernández García, Marta
  • Yanes, Óscar
  • Capellades, Jordi
  • Jankevics, Andris
  • Winder, Catherine
  • Falguera, Mireia
  • Franch-Nadal, Josep
  • Dunn, Warwick B.
  • Perera, Alexandre
  • Castelblanco Echavarría, Esmeralda
  • Mauricio Puente, Dídac
Background: In this study, we evaluated the lipidome alterations caused by type 1 diabetes (T1D) and type 2 diabetes (T2D), by determining lipids significantly associated with diabetes overall and in both sexes, and lipids associated with the glycaemic state. Methods: An untargeted lipidomic analysis was performed to measure the lipid profiles of 360 subjects (91 T1D, 91 T2D, 74 with prediabetes and 104 controls (CT)) without cardiovascular and/or chronic kidney disease. Ultra-high performance liquid chromatography-electrospray ionization mass spectrometry (UHPLC-ESI-MS) was conducted in two ion modes (positive and negative). We used multiple linear regression models to (1) assess the association between each lipid feature and each condition, (2) determine sex-specific differences related to diabetes, and (3) identify lipids associated with the glycaemic state by considering the prediabetes stage. The models were adjusted by sex, age, hypertension, dyslipidaemia, body mass index, glucose, smoking, systolic blood pressure, triglycerides, HDL cholesterol, LDL cholesterol, alternate Mediterranean diet score (aMED) and estimated glomerular filtration rate (eGFR); diabetes duration and glycated haemoglobin (HbA1c) were also included in the comparison between T1D and T2D. Results: A total of 54 unique lipid subspecies from 15 unique lipid classes were annotated. Lysophosphatidylcholines (LPC) and ceramides (Cer) showed opposite effects in subjects with T1D and subjects with T2D, LPCs being mainly up-regulated in T1D and down-regulated in T2D, and Cer being up-regulated in T2D and down-regulated in T1D. Also, Phosphatidylcholines were clearly down-regulated in subjects with T1D. Regarding sex-specific differences, ceramides and phosphatidylcholines exhibited important diabetes-associated differences due to sex. Concerning the glycaemic state, we found a gradual increase of a panel of 1-deoxyceramides from normoglycemia to prediabetes to T2D. Conclusions: Our findings revealed an extensive disruption of lipid metabolism in both T1D and T2D. Additionally, we found sex-specific lipidome changes associated with diabetes, and lipids associated with the glycaemic state that can be linked to previously described molecular mechanisms in diabetes., This work was funded by Spanish Ministry of Health, Instituto de Salud Carlos III (Madrid, Spain) grants PI15/0625 (to DM and EC), PI17/01362 (to NA), PI18/0328 (to DM), FEDER “Una manera de hacer Europa”, and by Fundació La Marató de TV3 2016 (303/C/2016) (201602.30.31) (to NA). Spanish Ministry of Economy and Competitiveness, grant PID2021-122952OB-I00 funded by AEI 10.13039/501100011033 and by ERDF A way of making Europe, Instituto de Salud Carlos III (grant AC22/00035); and the CERCA Programme / Generalitat de Catalunya (to AP). This research was supported by CIBER-Consorcio Centro de Investigación Biomèdica en Red-CIBERDEM (leading group CB15/00071) and Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Ministry of Science and Innovation. Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau is accredited by the Generalitat de Catalunya as Centre de Recerca de Catalunya (CERCA). B2SLab is certified as 2021 SGR 01052.
UPCommons. Portal del coneixement obert de la UPC
Publicación Contribución de congreso (ConferenceOutput)

Análisis no supervisado de registros de salud de COVID-19 mediante grafos y aprendizaje profundo

  • Gelabert Xirinachs, Joana|||0009-0000-4488-6817
  • Fonollosa Magrinyà, Jordi|||0000-0001-8854-8588
  • Perera Lluna, Alexandre|||0000-0001-6427-851X
El uso de grafos para analizar datos médicos permite representar la información como una red de nodos y conexiones. Esta técnica se aplica en varios campos por su capacidad de capturar relacio- nes complejas entre elementos. En este estudio, proponemos utili- zar grafos acíclicos dirigidos para representar la jerarquía de los códigos de diagnósticos ICD-10. Analizamos una base de datos que contiene información de casi 1,5 millones de usuarios del sistema de salud público catalán. El criterio de inclusión es un diagnóstico de Covid-19 entre el 01/01/2019 y el 01/09/2021. Disponemos del historial médico completo de cada paciente, así como otros datos demográficos. Utilizamos un algoritmo de aprendizaje automático no supervisado para aprender representaciones de los grafos de una subpoblación de aproximadamente 50.000 pacientes, poniendo el foco sobre la población con diabetes. El análisis del grueso de la población total ilustra la distribución de diagnósticos, con una me- dia de 4,6 diagnósticos únicos por paciente y una profundidad me- dia de los códigos ICD-10 de 4,4, siendo 7 la máxima profundidad posible. Los resultados de la aplicación del algoritmo al subcon- junto de individuos muestran una manera innovadora de resumir los datos de los pacientes y plantea potenciales investigaciones fu- turas en la predicción de trayectorias clínicas., Este trabajo ha sido apoyado por la Beca PID2021-122952OB-I00 financiada por la AEI 10.13039/501100011033 y por el ERDF A way of ma- king Europe; Centro de Investigación Biomédica en Red in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), iniciativas del Instituto de Investigación Carlos III (ISCIII); ISCIII (beca AC22/00035); y el Programa CERCA / Generalitat de Catalunya. B2SLab está certificado como 2021 SGR 01052. JF agradece el Plan Serra Húnter., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Phenotypic clustering of newly diagnosed type 2 diabetes in a Mediterranean cohort

  • Fernandez-Camins, Berta
  • Vlacho, Bogdan
  • Rojo-López, Marina Idalia
  • Granado-Casas, Minerva
  • Gratacòs, Mònica
  • Ortega-Bravo, Marta
  • Cendros-Massioui, Maria
  • Palmieri, Flavio|||0000-0002-1455-4923
  • Perera Lluna, Alexandre|||0000-0001-6427-851X
  • Franch-Nadal, Josep
  • Mauricio, Dídac
  • COPERNICAN Research Group, The
© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. Supplementary Information The online version contains supplementary material available at https://doi.org/10.1186/s12933-026-03198-w., Background: Current diagnostic criteria for type 2 diabetes (T2D) capture disease heterogeneity poorly, and do not reliably predict progression, complications, or treatment response. The phenotypic clustering model proposed by Ahlqvist et al. identified five T2D subtypes using six clinical variables at diagnosis, each associated with distinct metabolic profiles and complication risks. Although this framework has been replicated in several cohorts, evidence in Mediterranean populations is lacking. Methods We conducted a prospective cohort study in Catalonia (Northeast Spain) including adults with newly diagnosed T2D recruited between March 2022 and January 2026. Using baseline data, we evaluated the Ahlqvist clustering approach. Autoantibody-positive individuals were classified as severe autoimmune diabetes (SAID), and sex-stratified k-means clustering (k = 4) was applied to autoantibody-negative participants. Cluster separation and stability were assessed using principal component analysis and silhouette analyses. Results A final total number of 991 individuals with newly diagnosed T2D were included in the analysis. Autoantibodies were present in 67 subjects (6.8%), thereby being classified as SAID. Among the remaining 924 participants, sex-stratified k-means clustering (k = 4) identified clusters with metabolic profiles consistent with the classical subtypes: mild age-related diabetes (MARD, n = 326), severe insulin-resistant diabetes (SIRD, n = 241), mild obesity-related diabetes (MOD, n = 206), and severe insulin-deficient diabetes (SIDD, n = 151). However, cluster separation was modest, and bootstrap stability was limited (Jaccard 0.555–0.718). In an unconstrained analysis, apart from the autoimmune diabetes group, silhouette optimisation identified three clusters as the most internally optimal structure, corresponding broadly to obesity/insulin-resistant (C1, n = 347), insulin-deficient (C2, n = 186), and age- related (C3, n = 391) phenotypes. Stability was substantially higher for the three-cluster solution (Jaccard 0.799–0.863). Concordance between the Ahlqvist and data-driven models was moderate (ARI = 0.473), with MOD individuals distributed across the other clusters. Conclusions The Ahlqvist clustering architecture could be approximated in this Mediterranean cohort at diagnosis, but internal stability of the five-cluster solution was limited. In this population, a four-cluster structure showed substantially better internal validity. These findings support the feasibility of phenotypic subclassification of T2D., This research received financial support from the Spanish Ministry of Economy and Competitiveness (www.mineco.gob.es) PID2021-122952OB-I00, DPI2017- 89827-R and Instituto de Salud Carlos III, Ministry of Health (FIS PI21/01163). This work has been financed by a PERIS grant from the Primary Care Oriented Research Projects program with the reference number SLT021/21/000030 granted by the Generalitat de Catalunya (2022–2024). CIBER for Diabetes and Associated Metabolic Diseases (CIBERDEM; leading group CB15/00071) and the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), are initiatives of Instituto de Salud Carlos III (ISCIII). This research was also partially supported by an unrestricted grant from Menarini Group. The sponsor did not have any roles in the study design, collection, analysis, interpretation of data, writing of the report or the decision to submit the article for publication.
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Lipidome characterisation and sex-specific differences in type 1 and type 2 diabetes mellitus

  • Barranco Altirriba, María|||0000-0002-1525-210X
  • Alonso, Nuria
  • Weber, Ralf
  • Lloyd, Gavin R.
  • Hernández García, Marta
  • Yanes, Óscar
  • Capellades Tomàs, Jordi
  • Jankevics, Andris
  • Winder, Catherine
  • Falguera, Mireia
  • Franch Nadal, Josep
  • Dunn, Warwick B.
  • Perera Lluna, Alexandre|||0000-0001-6427-851X
  • Castelblanco, Esmeralda
  • Mauricio Puente, Dídac
Background: In this study, we evaluated the lipidome alterations caused by type 1 diabetes (T1D) and type 2 diabetes (T2D), by determining lipids significantly associated with diabetes overall and in both sexes, and lipids associated with the glycaemic state. Methods: An untargeted lipidomic analysis was performed to measure the lipid profiles of 360 subjects (91 T1D, 91 T2D, 74 with prediabetes and 104 controls (CT)) without cardiovascular and/or chronic kidney disease. Ultra-high performance liquid chromatography-electrospray ionization mass spectrometry (UHPLC-ESI-MS) was conducted in two ion modes (positive and negative). We used multiple linear regression models to (1) assess the association between each lipid feature and each condition, (2) determine sex-specific differences related to diabetes, and (3) identify lipids associated with the glycaemic state by considering the prediabetes stage. The models were adjusted by sex, age, hypertension, dyslipidaemia, body mass index, glucose, smoking, systolic blood pressure, triglycerides, HDL cholesterol, LDL cholesterol, alternate Mediterranean diet score (aMED) and estimated glomerular filtration rate (eGFR); diabetes duration and glycated haemoglobin (HbA1c) were also included in the comparison between T1D and T2D. Results: A total of 54 unique lipid subspecies from 15 unique lipid classes were annotated. Lysophosphatidylcholines (LPC) and ceramides (Cer) showed opposite effects in subjects with T1D and subjects with T2D, LPCs being mainly up-regulated in T1D and down-regulated in T2D, and Cer being up-regulated in T2D and down-regulated in T1D. Also, Phosphatidylcholines were clearly down-regulated in subjects with T1D. Regarding sex-specific differences, ceramides and phosphatidylcholines exhibited important diabetes-associated differences due to sex. Concerning the glycaemic state, we found a gradual increase of a panel of 1-deoxyceramides from normoglycemia to prediabetes to T2D. Conclusions: Our findings revealed an extensive disruption of lipid metabolism in both T1D and T2D. Additionally, we found sex-specific lipidome changes associated with diabetes, and lipids associated with the glycaemic state that can be linked to previously described molecular mechanisms in diabetes., This work was funded by Spanish Ministry of Health, Instituto de Salud Carlos III (Madrid, Spain) grants PI15/0625 (to DM and EC), PI17/01362 (to NA), PI18/0328 (to DM), FEDER “Una manera de hacer Europa”, and by Fundació La Marató de TV3 2016 (303/C/2016) (201602.30.31) (to NA). Spanish Ministry of Economy and Competitiveness, grant PID2021-122952OB-I00 funded by AEI 10.13039/501100011033 and by ERDF A way of making Europe, Instituto de Salud Carlos III (grant AC22/00035); and the CERCA Programme / Generalitat de Catalunya (to AP). This research was supported by CIBER-Consorcio Centro de Investigación Biomèdica en Red-CIBERDEM (leading group CB15/00071) and Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Ministry of Science and Innovation. Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau is accredited by the Generalitat de Catalunya as Centre de Recerca de Catalunya (CERCA). B2SLab is certified as 2021 SGR 01052., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Personalized air quality monitoring and respiratory health in moderate and severe asthma: findings from a six-month observational study

  • Marín López, Daniel
  • Escalona López, Sergio Vidal|||0000-0002-4771-8525
  • Salvador, Rosana Hernando
  • Alfaras Espinàs, Miquel
  • López Giraldo, Alejandra|||0000-0002-7415-1253
  • Lores Obradors, Luis
  • Sáez Zamora, José Alberto
  • Fonollosa Magrinyà, Jordi|||0000-0001-8854-8588
  • Haddi, Zouhair
Introduction Asthma affects over 339 million people worldwide, contributing substantially to morbidity, reduced quality of life, and premature mortality. Air pollution is a major risk factor, but stationary monitors lack the resolution to capture individual exposure. This study aimed to (i) evaluate the feasibility of integrating personalized air quality monitoring with digital health tools in patients with moderate-to-severe asthma; (ii) explore preliminary associations between pollutant exposures and respiratory outcomes; and (iii) characterize interrelations among symptoms, spirometry, wearable-derived physiology, and inhaler use. Methods: Thirteen adults with moderate-to-severe asthma participated in a six-month observational study using a digital monitoring ecosystem. This combined wearable sensors for physiological and air quality data, daily symptom reporting via smartphone, and spirometry assessments. Outdoor pollution data were obtained from the nearest fixed-site monitoring station. Results: Personal sensors revealed highly variable exposures that diverged from ambient measurements, particularly for nitrogen dioxide, which showed greater variability and more frequent exceedances of World Health Organization thresholds. Self-reported symptoms and inhaler use were strongly correlated. However, no consistent associations were observed between pollution exposure and health outcomes, including symptoms or spirometry results, even when time-lagged effects were considered. Conclusion: These findings highlight the limitations of relying on ambient stations to assess exposure in asthma research and underscore the importance of individualized monitoring. Combining wearable pollution sensors with continuous symptom tracking and remote lung function testing is feasible and patient-centered. This integrative approach may inform precision medicine strategies and improve individualized asthma management., This work was supported by the project A-IQ READY, which is cofunded by the European Union and by the Chips Joint Undertaking and its members under Grant Agreement No 101096658, the Spanish Ministry of Economy and Competitiveness (www.mineco.gob.es) PID2021- 122952OB-I00, Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBERBBN), initiatives of Instituto de Investigación Carlos III (ISCIII), and ISCIII (grant AC22/00035), Pla de Doctorats Industrials de la Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya (2022 DI 014 and 2020 DI 115) and funded by MCIU/AEI/10.13039/501100011033 and European Union (ref PCI2025-163263). We acknowledge CERCA Programme/Generalitat de Catalunya. JF acknowledges the support from the Serra Húnter program. B2SLab is certified as 2021 SGR 01052., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Proof of concept for an age- and inflammation-adjusted model for the establishment of pediatric serum copper reference intervals

  • Rodríguez González, Helena
  • Arias, Ángela
  • Poyatos, Elisabet
  • Mercedes de los Santos, Mariela
  • Minguez, Beatriz
  • Meavilla, Silvia
  • Garcia Volpe, Camila
  • Loverdos, Ines
  • Molera, Cristina
  • Casado Río, Mercedes
  • Ormazábal, Aida
  • Perera Lluna, Alexandre|||0000-0001-6427-851X
  • Artuch, Rafael
Background & aims: Copper is a trace element essential for enzymatic reactions, but excessive accumulation can cause toxicity. Accurate interpretation of serum copper concentrations is crucial for diagnosing conditions such as Wilson's disease, liver dysfunction, and nutritional deficiencies. Current reference intervals often ignore the effect of inflammation and are typically established using discrete age groups rather than modelling age as a continuous variable. This study aimed to establish continuous, age-adjusted reference intervals for serum copper and to develop a method for correcting inflammation-related variability. Methods We retrospectively analyzed serum copper concentrations in a pediatric cohort of 4,368 unique samples. Inflammatory status was assessed using erythrocyte sedimentation rate (ESR), fibrinogen, and C-reactive protein (CRP). Samples without inflammation were used to generate age-continuous reference intervals through polynomial regression. To quantify and adjust for inflammation effects, we developed a composite inflammation score using partial least squares regression on standardized values of the three acute-phase markers and applied it to correct copper concentrations in samples exhibiting inflammation. Results Serum copper showed a nonlinear relationship with age. Inflammation elevated copper concentrations by approximately 24 %. The composite inflammation score independently predicted this variability in copper concentrations, and adjustment using the score restored copper concentrations within reference limits, reducing the risk of data misinterpretation. Conclusion Our findings underscore the necessity of considering both age and inflammation variables when interpreting pediatric serum copper concentrations. We provide continuous, age-adjusted reference intervals and a method to correct for inflammation-related variability, enhancing data interpretation. We propose a proof-of-concept potentially applicable to other biomarkers related with metabolic and nutritional disturbances in chronic and acute diseases., This study was supported by Grant PID2021-122952OB-I00 funded by AEI 10.13039/501100011033 and by ERDF, a way of making Europe; the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) initiatives of Instituto de Salud Carlos III (ISCIII); ISCIII (grant AC22/00035); and the CERCA Programme/Generalitat de Catalunya. B2SLab is certified as 2021 SGR 01052. HRG and RA were supported by project Impact Únicas “PMP22/00008”, financed by the ISCIII under the NextGenerationEU Funds of the European Union., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Signal preprocessing in instrument-based electronic noses leads to parsimonious predictive models: application to olive oil quality control

  • Fernández Romero, Luis
  • Oller-Moreno, Sergi
  • Fonollosa Magrinyà, Jordi|||0000-0001-8854-8588
  • Garrido Delgado, Rocío
  • Arce Jiménez, Lourdes
  • Martín-Gómez, Andrés
  • Marco Colás, Santiago
  • Pardo Martínez, Antonio
Gas sensor-based electronic noses (e-noses) have gained considerable attention over the past thirty years, leading to the publication of numerous research studies focused on both the development of these instruments and their various applications. Nonetheless, the limited specificity of gas sensors, along with the common requirement for chemical identification, has led to the adaptation and incorporation of analytical chemistry instruments into the e-nose framework. Although instrument-based e-noses exhibit greater specificity to gasses than traditional ones, they still produce data that require correction in order to build reliable predictive models. In this work, we introduce the use of a multivariate signal processing workflow for datasets from a multi-capillary column ion mobility spectrometer-based e-nose. Adhering to the electronic nose philosophy, these workflows prioritized untargeted approaches, avoiding dependence on traditional peak integration techniques. A comprehensive validation process demonstrates that the application of this preprocessing strategy not only mitigates overfitting but also produces parsimonious models, where classification accuracy is maintained with simpler, more interpretable structures. This reduction in model complexity offers significant advantages, providing more efficient and robust models without compromising predictive performance. This strategy was successfully tested on an olive oil dataset, showcasing its capability to improve model parsimony and generalization performance, This research was funded by Spanish Ministerio de asuntos económicos y transformacion digital (MINECO) project TargetML (PID2021-126543OB-C21) and project BIOMADS (PID2021-122952OB-I00). Additional financial support was provided by the Institut de Bioenginyeria de Catalunya (IBEC). IBEC is a member of the CERCAProgramme/Generalitat de Catalunya. The authors would also like to acknowledge the Departament d’Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya (expedient 2021 SGR 01393 and expedient 2021 SGR 01052, B2SLab). This study was supported by the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN, Spain), the initiatives of Instituto de Investigación Carlos III (ISCIII), ISCIII (grant AC22/00035), Pla de Doctorats Industrials de la Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya (2022 DI 014). JF acknowledges the support from the Serra Húnter program. L.F., S.M., and A.P. express their gratitude for the support provided by the Department of Electronics and Biomedical Engineering, Universitat de Barcelona (UB)., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

The dilemma of variables assumptions in thermal comfort calculations for educational buildings: to simplify or not?

  • Ruiz de Alegría Sala, Alba|||0000-0001-7149-6873
  • Marín López, Daniel
  • Canals Casals, Lluc|||0000-0002-4791-9917
  • Fonollosa Magrinyà, Jordi|||0000-0001-8854-8588
  • Macarulla Martí, Marcel|||0000-0002-5469-7291
Thermal comfort is crucial for people well-being and productivity in buildings, and it has a strong effect on building’s energy usage. The main models for assessing thermal comfort, like predictive mean vote (PMV) and adaptive models, need many environmental measurements, making monitoring complex. That has sparked a debate: some advocate reducing the number of variables, while others stress sticking to the original models. This article evaluates current research trends and addresses the limitations of globe sensors, the most commonly used instrument for measuring mean radiant temperature. To address these is- sues, the study conducts a sensitivity analysis using latin hypercube sampling with multidimen- sional uniformity and employs data from 41 measurements conducted in educational buildings spanning different academic levels, from preschool to university. This analysis examines various simplifications in the measuring procedures for the PMV and adaptive models proposed by ASHRAE 55, ISO 7730 and EN 16798. For this purpose, two mean radiant temperature accuracies are used according to the minimum requirement and the desired value specified by ISO 7726, ±2 ¿C and ±0.2 ¿ C respectively. The results suggest that models with fewer variables tend to overestimate thermal comfort levels. However, this models are valid as their estimations fall within the uncertainty range of the complete model, as long as the mean radiant temperature accuracy is ±2 ¿C as achieved with globe sensors. When mean radiant temperature accuracy improves (i.e. ±0.2 ¿C), the outcome of the models with less variables imply an overestimation falling out of the uncertainty of the complete model., This study is supported by “ComMit-20 – 2020PANDE00116” project funded by L’Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) through the Pandèmies 2020 programme; MOVE4EDU “Modular ventilation system integrated with urban food production in educational buildings" project, reference PID2021-126845OB-C22, funded by MCIN/AEI/10.13039/501100011033 and, by “ ERDF A way of making Europe”; Catalan Agency AGAUR under their research group support program (2021 SGR 00341, 2021 SGR 00226 and 2021 SGR 01052); Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN, Spain), initiatives of Instituto de Investigación Carlos III (ISCIII); ISCIII (grant AC22/00035); ACCI Ó (grant Innotec ACE014/20/000018); the Spanish Ministry of Economy and Competitiveness (www.mineco.gob.es) PID2021- 122952OB-I00; Pla de Doctorats Industrials de la Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya (2022 DI 014); and CERCA Program/Generalitat de Catalunya. JF and LCC also acknowledge the Serra Húnter Program.
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Cerebrospinal amino acid profiling in a large cohort of neuropediatric patients with epilepsy

  • Rodríguez González, Helena
  • Nou Fontanet, Laia
  • Ormazábal, Aida
  • Casado Río, Mercedes
  • Arias, Angela
  • Pias Peleteiro, Leticia
  • Gutierrez, Ana
  • Perera Lluna, Alexandre|||0000-0001-6427-851X
  • García Cazorla, Ángeles
  • Fons Escupiñà, Maria Carme
  • Artuch, Rafael
This study addresses challenges in cerebrospinal fluid (CSF) amino acid profiling in pediatric neurological disorders by establishing age-continuous reference intervals. It examines amino acid variations in epilepsy of different etiologies and evaluates the effects of antiseizure medications (ASMs), resolving inconsistencies in previous research. We retrospectively analyzed 410 CSF samples from pediatric patients (201 with epilepsy). Reference intervals were established using linear regression, adjusting for age and sex as confounders. Statistical analysis of age-normalized data included tests to assess the relationship between clinical features and altered or normal amino acid levels, multiple regression models evaluating the effects of ASMs on CSF amino acid levels, and hierarchical clustering for pattern identification. Age significantly influenced CSF amino acid levels, with higher concentrations observed in neonates, except for aspartic acid and arginine. Sex was not a significant predictor. Over 90 % of patients with epilepsy had normal levels for most amino acids, except for glutamine, which was more frequently elevated in epilepsy. Valproate and GABAA receptor agonists were linked to elevated glutamine, while vigabatrin therapy was associated with increased levels of ornithine, leucine, and isoleucine. Hierarchical clustering identified a subcluster with elevated essential amino acid levels, predominantly comprising patients with generalized seizures or status epilepticus. This study establishes new CSF amino acid reference intervals for pediatric patients and finds no significant associations between individual amino acid levels and epilepsy-related clinical features. However, a subgroup with high essential amino acid levels, primarily associated with generalized epilepsy, suggests potential links to generalized epileptogenic discharges and blood–brain barrier disruption., This work was supported by Grant PID2021-122952OB-I00 funded by AEI 10.13039/501100011033 and by ERDF, a way of making Europe; the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) initiatives of Instituto de Salud Carlos III (ISCIII); ISCIII (grant AC22/00035); and the CERCA Programme / Generalitat de Catalunya. B2SLab is certified as 2021 SGR 01052. CF was supported by PI22/01441 from Instituto de Salud Carlos III (ISCIII, Spain). HRG was supported by project Impact Únicas PMP22/00008 funded by, as appropriate, by Instituto de Salud Carlos III (ISCIII) under the “European Union NextGenerationEU/PRTR”., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes

  • Barranco Altirriba, María|||0000-0002-1525-210X
  • Rossell, Joana
  • Alonso Pedrol, Núria
  • Weber, Ralf
  • Ortega, Emilio
  • Lloyd, Gavin R.
  • Hernández García, Marta
  • Yanes, Óscar
  • Capellades Tomàs, Jordi
  • Winder, Catherine
  • Junza, Alexandra
  • Falguera, Mireia
  • Franch Nadal, Josep
  • Dunn, Warwick B.
  • Perera Lluna, Alexandre|||0000-0001-6427-851X
  • Castelblanco, Esmeralda
  • Mauricio Puente, Dídac
Background. Disruption of lipid metabolism contributes to increased cardiovascular risk in diabetes. Methods. We evaluated the associations between serum lipidomic profile and subclinical carotid atherosclerosis (SCA) in type 1 (T1D) and type 2 (T2D) diabetes, and in subjects without diabetes (controls) in a cross-sectional study. All subjects underwent a lipidomic analysis using ultra-high performance liquid chromatography–electrospray ionization tandem mass spectrometry, carotid ultrasound (mode B) to assess SCA, and clinical assessment. Multiple linear regression models were used to assess the association between features and the presence and burden of SCA in subjects with T1D, T2D, and controls separately. Additionally, multiple linear regression models with interaction terms were employed to determine features significantly associated with SCA within risk groups, including smoking habit, hypertension, dyslipidaemia, antiplatelet use and sex. Depending on the population under study, different confounding factors were considered and adjusted for, including sample origin, sex, age, hypertension, dyslipidaemia, body mass index, waist circumference, glycated haemoglobin, glucose levels, smoking habit, diabetes duration, antiplatelet use, and alanine aminotransferase levels. Results. A total of 513 subjects (151 T1D, 155 T2D, and 207 non-diabetic control) were included, in whom the percentage with SCA was 48.3%, 49.7%, and 46.9%, respectively. A total of 27 unique lipid species were associated with SCA in subjects with T2D, in former/current smokers with T2D, and in individuals with T2D without dyslipidaemia. Phosphatidylcholines and diacylglycerols were the main SCA-associated lipidic classes. Ten different species of phosphatidylcholines were up-regulated, while 4 phosphatidylcholines containing polyunsaturated fatty acids were down-regulated. One diacylglycerol was down-regulated, while the other 3 were positively associated with SCA in individuals with T2D without dyslipidaemia. We discovered several features significantly associated with SCA in individuals with T1D, but only one sterol could be partially annotated. Conclusions. We revealed a significant disruption of lipid metabolism associated with SCA in subjects with T2D, and a larger SCA-associated disruption in former/current smokers with T2D and individuals with T2D who do not undergo lipid-lowering treatment., This work was funded by Spanish Ministry of Health, Instituto de Salud Carlos III (Madrid, Spain) grants PI15/0625 (to DM and EC), PI17/01362 (to NA), PI18/0328 (to DM), FEDER “Una manera de hacer Europa”, and by Fundació La Marató de TV3 2016 (303/C/2016) (201602.30.31) (to NA). This work was supported by the Grant PID2021-122952OB-I00 funded by AEI https:/ /doi. org/10.13039/501100011033 and by ERDF A way of making Europe (to AP). This research was supported by Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders (CIBERDEM–CB15/00071) (to DM) and Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), initiatives of Instituto de Investigación Carlos III (ISCIII); ISCIII (grant AC22/00035) (to AP); and the CERCA Programme / Generalitat de Catalunya. B2SLab is certified as 2021 SGR 01052. Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau is accredited by the Generalitat de Catalunya as Centre de Recerca de Catalunya (CERCA)., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Mediterranean diet is a predictor of progression of subclinical atherosclerosis in a mediterranean population: the ILERVAS prospective cohort study

  • Rojo López, Marina Idalia
  • Bermudez Lopez, Marcelino
  • Castro Boqué, Eva
  • Farràs Sallés, Cristina
  • Torres Cortada, Gerard
  • Pamplona Gras, Reinald
  • Lecube Torelló, Albert
  • Valdivieso Revilla, José Manuel
  • Fernández Giráldez, Elvira
  • Julve Gil, Josep
  • Castelblanco, Esmeralda
  • Alonso Pedrol, Núria
  • Antentas, Maria
  • Barranco Altirriba, María|||0000-0002-1525-210X
  • Perera Lluna, Alexandre|||0000-0001-6427-851X
  • Franch Nadal, Josep
  • Granado Casas, Minerva
  • Mauricio Puente, Dídac
Atherosclerotic cardiovascular disease remains a major health issue, often developing silently as subclinical atherosclerotic disease (SAD). The Mediterranean diet (MDiet) is known for its cardiovascular benefits, but the combined influence of both MDiet adherence and physical activity (PA) on SAD progression has not been previously documented. Objective: We aimed to investigate how adherence to a healthy lifestyle, defined as MDiet adherence and PA level, influences SAD progression in subjects from the ILERVAS cohort follow-up. Methods: A study on 3097 participants from the ILERVAS prospective cohort was conducted. MDiet adherence was assessed using the MEDAS score, and PA categories were established using the IPAQ, both categorized into low, moderate, and high levels. Two different lifestyle scores integrating the MDiet and PA categories were built. The presence of atherosclerotic plaques was assessed by carotid and femoral ultrasound examination. Demographic, clinical, and biochemical data were also obtained. Multivariable linear, logistic, and Poisson regression models adjusted for potential confounders were used to analyze the association between the lifestyle scores and SAD progression, as well as the MDiet and PA as separate variables and number of territories with plaque. Results: A healthier lifestyle score did not show an effect on SAD progression. However, a higher MEDAS score was associated with a 3% decrease in the number of territories with plaque (IRR 0.97, 95% CI 0.96–0.99, p < 0.001), suggesting a protective effect of the adherence to the MDiet. PA did not show a significant association (IRR 1.00, 95% CI 1.00–1.00, p = 0.269). Older age, hypertension, dyslipidemia, smoking, and lower eGFR were associated with SAD progression, while the female sex was protective (IRR 0.67, 95% CI 0.63–0.72, p < 0.001). Conclusions: The findings of this study show that higher adherence to the MDiet is associated with reduced incidence of SAD, indicating its potential role in cardiovascular prevention strategies. Although a higher lifestyle score or physical activity levels did not show any significant effect, promoting the MDiet, alongside managing traditional cardiovascular risk factors, could be an effective public health intervention to prevent atherosclerosis and reduce the burden of cardiovascular disease., This research was supported by the CIBER-Consorcio Centro de Investigación Biomédica en Red-(CB15/00071), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Spain. M.I.R.-L. holds a predoctoral grant SLT017/20/000107 from Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2021–2024 of Generalitat de Catalunya. JJ has received financial support from the Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033 and the European Union “NextGeneration EU”/PRTR) within the action “Consolidación Investigadora 2022” (CNS2022-135559) and Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Madrid, Spain), grant PI21/00770 (to J.J.), FEDER “Una manera de hacer Europa”. M Bermúdez-López holds a postdoctoral grant funded by the Ministerio de Ciencia, Innovación y Universidades (IJC2018-037792-I). This research was also funded by the Ministerio de Ciencia, Innovación y Universidades (grant PID2023-152233OB-I00, co-funded by the European Regional Development Fund, “A way to build Europe”), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) and Department of Health (SLT002/16/00250) to R.P. This work was supported by grants from the Diputació de Lleida, Instituto de Salud Carlos III (RETIC RD16/0009/0011). This work was also supported by the Grant PID2021-122952OB-I00 funded by AEI 10.13039/501100011033 and by ERDF A way of making Europe; the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), initiatives of Instituto de Investigación Carlos III (ISCIII); ISCIII (grant AC22/00035); and the CERCA Programme/Generalitat de Catalunya. B2SLab is certified as 2021 SGR 01052. Institut d’Investigació Biomèdica Sant Pau and Biomedical Research Institute’s Dr. Pifarré Foundation from Lleida (IRBLleida) are accredited by the Generalitat de Catalunya as Centre de Recerca de Catalunya (CERCA)., Peer Reviewed, Membres del ILERVAS project: Eva Miquel, Marta Ortega, Ferran Barbé, Jessica González, Silvia Barril, Manuel Sánchez-de-la-Torre, Manuel Portero-Otín, Mariona Jové, Marta Hernández, Ferran Rius, Pere Godoy and Montse Martinez-Alonso.
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Predictive epigenetic biomarkers of successful weight-loss intervention in pre-pubertal children with obesity

  • Palmieri, Flavio|||0000-0002-1455-4923
  • Castellano Escuder, Pol
  • Parra-Vargas, Marcela
  • Leal Witt, Maria Jesus
  • Ramon-Krauel, Marta
  • Lerin, Carles
  • Perera Lluna, Alexandre|||0000-0001-6427-851X
  • Jiménez Chillarón, José Carlos
Childhood obesity represents a major public health challenge, increasing long-term risks such as type 2 diabetes and cardiovascular disease. Lifestyle interventions in prepubertal children are often more effective, but individual responses can vary, highlighting the need for predictive biomarkers to personalize treatment. This study investigated DNA methylation profiles in prepubertal children living with obesity to identify possible epigenetic markers that could predict the success of weight loss interventions. We analyzed a cohort of 26 children who underwent a six-month lifestyle intervention focused on dietary modifications. From 214 differentially methylated CpG sites between high and low responders, we narrowed these to eight key markers. These markers were used to develop a predictive model with a precision 84% in classifying children based on their BMI normalized to changes in the z-score of the age. CpGs were found in genes such as GSDMD, GFRA1 and NRP2, all linked to pathways involved in inflammation, metabolic regulation, and lipid metabolism, which are crucial in the development of obesity. The results suggest that DNA methylation signatures can predict weight loss responses in prepubertal children, offering a novel approach to early-stage obesity intervention. These findings hold promise for the development of personalized treatment strategies in pediatric obesity. However, larger and more diverse cohort studies are needed to confirm the generalizability of these markers and refine the predictive model for broader clinical use., This study was supported by the Spanish Ministry of Science and Innovation (MCIN) (PID2021-126441NB-I00 to J. C. J. C., co-funded by the European Regional Development Fund [ERDF]), the Government of Catalonia (2017SGR845 to J. C. J. C.), and Pfizer Global Grants (Pfizer Tracking No. 76587213 to J. C. J. C.). This work was also supported by the Grant PID2021-122952OB-I00 funded by AEI 10.13039/501100011033 and by ERDF A way of making Europe; the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), initiatives of Instituto de Investigación Carlos III (ISCIII); ISCIII (grant AC22/00035); and the CERCA Programme / Generalitat de Catalunya. B2SLab is certified as 2021 SGR 01052. F. P. expresses gratitude for the support received through the Juan de la Cierva fellowship ID JDC2022-049039-I, cofunded by MCIN/AEI/10.13039/501100011033 and the European Union - NextGenerationEU/PRTR.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Análisis no supervisado de registros de salud de COVID-19 mediante grafos y aprendizaje profundo

  • Gelabert Xirinachs, Joana
  • Fonollosa Magrinyà, Jordi
  • Perera Lluna, Alexandre
El uso de grafos para analizar datos médicos permite representar la información como una red de nodos y conexiones. Esta técnica se aplica en varios campos por su capacidad de capturar relacio- nes complejas entre elementos. En este estudio, proponemos utili- zar grafos acíclicos dirigidos para representar la jerarquía de los códigos de diagnósticos ICD-10. Analizamos una base de datos que contiene información de casi 1,5 millones de usuarios del sistema de salud público catalán. El criterio de inclusión es un diagnóstico de Covid-19 entre el 01/01/2019 y el 01/09/2021. Disponemos del historial médico completo de cada paciente, así como otros datos demográficos. Utilizamos un algoritmo de aprendizaje automático no supervisado para aprender representaciones de los grafos de una subpoblación de aproximadamente 50.000 pacientes, poniendo el foco sobre la población con diabetes. El análisis del grueso de la población total ilustra la distribución de diagnósticos, con una me- dia de 4,6 diagnósticos únicos por paciente y una profundidad me- dia de los códigos ICD-10 de 4,4, siendo 7 la máxima profundidad posible. Los resultados de la aplicación del algoritmo al subcon- junto de individuos muestran una manera innovadora de resumir los datos de los pacientes y plantea potenciales investigaciones fu- turas en la predicción de trayectorias clínicas., Este trabajo ha sido apoyado por la Beca PID2021-122952OB-I00 financiada por la AEI 10.13039/501100011033 y por el ERDF A way of ma- king Europe; Centro de Investigación Biomédica en Red in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), iniciativas del Instituto de Investigación Carlos III (ISCIII); ISCIII (beca AC22/00035); y el Programa CERCA / Generalitat de Catalunya. B2SLab está certificado como 2021 SGR 01052. JF agradece el Plan Serra Húnter., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Predictive epigenetic biomarkers of successful weight-loss intervention in pre-pubertal children with obesity

  • Palmieri, Flavio
  • Castellano Escuder, Pol
  • Parra-Vargas, Marcela
  • Leal Witt, Maria Jesus
  • Ramon-Krauel, Marta
  • Lerin, Carles
  • Perera Lluna, Alexandre
  • Jiménez Chillarón, José Carlos
Childhood obesity represents a major public health challenge, increasing long-term risks such as type 2 diabetes and cardiovascular disease. Lifestyle interventions in prepubertal children are often more effective, but individual responses can vary, highlighting the need for predictive biomarkers to personalize treatment. This study investigated DNA methylation profiles in prepubertal children living with obesity to identify possible epigenetic markers that could predict the success of weight loss interventions. We analyzed a cohort of 26 children who underwent a six-month lifestyle intervention focused on dietary modifications. From 214 differentially methylated CpG sites between high and low responders, we narrowed these to eight key markers. These markers were used to develop a predictive model with a precision 84% in classifying children based on their BMI normalized to changes in the z-score of the age. CpGs were found in genes such as GSDMD, GFRA1 and NRP2, all linked to pathways involved in inflammation, metabolic regulation, and lipid metabolism, which are crucial in the development of obesity. The results suggest that DNA methylation signatures can predict weight loss responses in prepubertal children, offering a novel approach to early-stage obesity intervention. These findings hold promise for the development of personalized treatment strategies in pediatric obesity. However, larger and more diverse cohort studies are needed to confirm the generalizability of these markers and refine the predictive model for broader clinical use., This study was supported by the Spanish Ministry of Science and Innovation (MCIN) (PID2021-126441NB-I00 to J. C. J. C., co-funded by the European Regional Development Fund [ERDF]), the Government of Catalonia (2017SGR845 to J. C. J. C.), and Pfizer Global Grants (Pfizer Tracking No. 76587213 to J. C. J. C.). This work was also supported by the Grant PID2021-122952OB-I00 funded by AEI 10.13039/501100011033 and by ERDF A way of making Europe; the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), initiatives of Instituto de Investigación Carlos III (ISCIII); ISCIII (grant AC22/00035); and the CERCA Programme / Generalitat de Catalunya. B2SLab is certified as 2021 SGR 01052. F. P. expresses gratitude for the support received through the Juan de la Cierva fellowship ID JDC2022-049039-I, cofunded by MCIN/AEI/10.13039/501100011033 and the European Union - NextGenerationEU/PRTR., Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Signal preprocessing in instrument-based electronic noses leads to parsimonious predictive models: application to olive oil quality control

  • Fernández Romero, Luis
  • Oller-Moreno, Sergi
  • Fonollosa Magrinyà, Jordi
  • Garrido Delgado, Rocío
  • Arce Jiménez, Lourdes
  • Martín-Gómez, Andrés
  • Marco Colás, Santiago
  • Pardo Martínez, Antonio
Gas sensor-based electronic noses (e-noses) have gained considerable attention over the past thirty years, leading to the publication of numerous research studies focused on both the development of these instruments and their various applications. Nonetheless, the limited specificity of gas sensors, along with the common requirement for chemical identification, has led to the adaptation and incorporation of analytical chemistry instruments into the e-nose framework. Although instrument-based e-noses exhibit greater specificity to gasses than traditional ones, they still produce data that require correction in order to build reliable predictive models. In this work, we introduce the use of a multivariate signal processing workflow for datasets from a multi-capillary column ion mobility spectrometer-based e-nose. Adhering to the electronic nose philosophy, these workflows prioritized untargeted approaches, avoiding dependence on traditional peak integration techniques. A comprehensive validation process demonstrates that the application of this preprocessing strategy not only mitigates overfitting but also produces parsimonious models, where classification accuracy is maintained with simpler, more interpretable structures. This reduction in model complexity offers significant advantages, providing more efficient and robust models without compromising predictive performance. This strategy was successfully tested on an olive oil dataset, showcasing its capability to improve model parsimony and generalization performance, This research was funded by Spanish Ministerio de asuntos económicos y transformacion digital (MINECO) project TargetML (PID2021-126543OB-C21) and project BIOMADS (PID2021-122952OB-I00). Additional financial support was provided by the Institut de Bioenginyeria de Catalunya (IBEC). IBEC is a member of the CERCAProgramme/Generalitat de Catalunya. The authors would also like to acknowledge the Departament d’Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya (expedient 2021 SGR 01393 and expedient 2021 SGR 01052, B2SLab). This study was supported by the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN, Spain), the initiatives of Instituto de Investigación Carlos III (ISCIII), ISCIII (grant AC22/00035), Pla de Doctorats Industrials de la Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya (2022 DI 014). JF acknowledges the support from the Serra Húnter program. L.F., S.M., and A.P. express their gratitude for the support provided by the Department of Electronics and Biomedical Engineering, Universitat de Barcelona (UB)., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Lipidome characterisation and sex-specific differences in type 1 and type 2 diabetes mellitus

  • Barranco Altirriba, María
  • Alonso, Núria
  • Weber, Ralf J. M.
  • Lloyd, Gavin R.
  • Hernández García, Marta
  • Yanes, Óscar
  • Capellades, Jordi
  • Jankevics, Andris
  • Winder, Catherine
  • Falguera, Mireia
  • Franch-Nadal, Josep
  • Dunn, Warwick B.
  • Perera, Alexandre
  • Castelblanco Echavarría, Esmeralda
  • Mauricio Puente, Dídac
Background: In this study, we evaluated the lipidome alterations caused by type 1 diabetes (T1D) and type 2 diabetes (T2D), by determining lipids significantly associated with diabetes overall and in both sexes, and lipids associated with the glycaemic state. Methods: An untargeted lipidomic analysis was performed to measure the lipid profiles of 360 subjects (91 T1D, 91 T2D, 74 with prediabetes and 104 controls (CT)) without cardiovascular and/or chronic kidney disease. Ultra-high performance liquid chromatography-electrospray ionization mass spectrometry (UHPLC-ESI-MS) was conducted in two ion modes (positive and negative). We used multiple linear regression models to (1) assess the association between each lipid feature and each condition, (2) determine sex-specific differences related to diabetes, and (3) identify lipids associated with the glycaemic state by considering the prediabetes stage. The models were adjusted by sex, age, hypertension, dyslipidaemia, body mass index, glucose, smoking, systolic blood pressure, triglycerides, HDL cholesterol, LDL cholesterol, alternate Mediterranean diet score (aMED) and estimated glomerular filtration rate (eGFR); diabetes duration and glycated haemoglobin (HbA1c) were also included in the comparison between T1D and T2D. Results: A total of 54 unique lipid subspecies from 15 unique lipid classes were annotated. Lysophosphatidylcholines (LPC) and ceramides (Cer) showed opposite effects in subjects with T1D and subjects with T2D, LPCs being mainly up-regulated in T1D and down-regulated in T2D, and Cer being up-regulated in T2D and down-regulated in T1D. Also, Phosphatidylcholines were clearly down-regulated in subjects with T1D. Regarding sex-specific differences, ceramides and phosphatidylcholines exhibited important diabetes-associated differences due to sex. Concerning the glycaemic state, we found a gradual increase of a panel of 1-deoxyceramides from normoglycemia to prediabetes to T2D. Conclusions: Our findings revealed an extensive disruption of lipid metabolism in both T1D and T2D. Additionally, we found sex-specific lipidome changes associated with diabetes, and lipids associated with the glycaemic state that can be linked to previously described molecular mechanisms in diabetes., This work was funded by Spanish Ministry of Health, Instituto de Salud Carlos III (Madrid, Spain) grants PI15/0625 (to DM and EC), PI17/01362 (to NA), PI18/0328 (to DM), FEDER “Una manera de hacer Europa”, and by Fundació La Marató de TV3 2016 (303/C/2016) (201602.30.31) (to NA). Spanish Ministry of Economy and Competitiveness, grant PID2021-122952OB-I00 funded by AEI 10.13039/501100011033 and by ERDF A way of making Europe, Instituto de Salud Carlos III (grant AC22/00035); and the CERCA Programme / Generalitat de Catalunya (to AP). This research was supported by CIBER-Consorcio Centro de Investigación Biomèdica en Red-CIBERDEM (leading group CB15/00071) and Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Ministry of Science and Innovation. Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau is accredited by the Generalitat de Catalunya as Centre de Recerca de Catalunya (CERCA). B2SLab is certified as 2021 SGR 01052.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Characterisation of type 2 diabetes subgroups at diagnosis: the COPERNICAN prospective observational cohort study protocol

  • Fernandez Camins, Berta
  • Vlacho, Bogdan
  • Canudas Ventura, Albert
  • Ortega Bravo, Marta
  • Granado Casas, Minerva
  • Perera-Lluna, Alexandre
  • Boluda-Sanson, Alejandro
  • El-Khattabi-Ofkir, Yesmina
  • Franch-Nadal, Josep
  • Mauricio Puente, Dídac
Introduction Type 2 diabetes mellitus (T2DM) is a highly heterogeneous and complex metabolic disease harbouring different metabolic characteristics. Adequate characterisation of subjects is essential to allow the implementation of precision medicine for the prevention, diagnosis, prognosis and treatment of this condition. Methods and analysis This prospective observational cohort study aims to identify and characterise relevant clinical clusters that are reproducibly associated with various clinical outcomes in T2DM in our Mediterranean region. The COPERNICAN study will include 1200 subjects with newly diagnosed T2DM from 28 primary care centres from the city of Barcelona and the healthcare district of Lleida in Catalonia (Spain). Participants will undergo a comprehensive phenotypic evaluation including, among others, six relevant variables: age, antibodies against glutamic acid decarboxylase, body mass index, glycated haemoglobin (HbA1c), indexes of insulin sensibility (HOMA2-IR) and secretion (HOMA2-beta). We will collect additional comprehensive data on glucose-lowering and other drug treatments, clinical evaluation (including complications), laboratory parameters, advanced lipoprotein profile, dietary habits and physical activity. The linkage with the population database will be done to perform a pragmatic follow-up of participants as part of their usual clinical care. A state-of-the-art cluster analysis (k-means and hierarchical clustering) will be performed. Ethics and dissemination The present study complies with all the ethical aspects and protection of participant subjects complying with all current local and European Union legislation. All Ethics Committees from the institutions involved in the study (IR Sant Pau Ethics Committee, Ethics Committee for Drug Research at IDIAP Jordi Gol and University Hospital of Bellvitge Ethics Committee for Research) approved this protocol. Confidentiality and anonymity of the data are ensured according to the current Spanish Organic Law 3/2018 of 05 December. Trial registration number ClinicalTrials.gov. registration number NCT05333718, 27 January 2023., This research received financial support from the Spanish Ministry of Economy and Competitiveness (www.mineco.gob.es) PID2021-122952OB-I00, DPI2017-89827-R and Instituto de Salud Carlos III, Ministry of Health (PI21/01163). This work has been financed by a PERIS grant from the Primary Care Oriented Research Projects program with the reference number SLT021/21/000030 granted by the Generalitat de Catalunya (2022-2024). CIBER for Diabetes and Associated Metabolic Diseases (CIBERDEM; leading group CB15/00071) and the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), are initiatives of Instituto de Salud Carlos III (ISCIII)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes

  • Barranco Altirriba, María
  • Rossell, Joana
  • Alonso Pedrol, Núria
  • Weber, Ralf
  • Ortega, Emilio
  • Lloyd, Gavin R.
  • Hernández García, Marta
  • Yanes, Óscar
  • Capellades Tomàs, Jordi
  • Winder, Catherine
  • Junza, Alexandra
  • Falguera, Mireia
  • Franch Nadal, Josep
  • Dunn, Warwick B.
  • Perera Lluna, Alexandre
  • Castelblanco, Esmeralda
  • Mauricio Puente, Dídac
Background. Disruption of lipid metabolism contributes to increased cardiovascular risk in diabetes. Methods. We evaluated the associations between serum lipidomic profile and subclinical carotid atherosclerosis (SCA) in type 1 (T1D) and type 2 (T2D) diabetes, and in subjects without diabetes (controls) in a cross-sectional study. All subjects underwent a lipidomic analysis using ultra-high performance liquid chromatography–electrospray ionization tandem mass spectrometry, carotid ultrasound (mode B) to assess SCA, and clinical assessment. Multiple linear regression models were used to assess the association between features and the presence and burden of SCA in subjects with T1D, T2D, and controls separately. Additionally, multiple linear regression models with interaction terms were employed to determine features significantly associated with SCA within risk groups, including smoking habit, hypertension, dyslipidaemia, antiplatelet use and sex. Depending on the population under study, different confounding factors were considered and adjusted for, including sample origin, sex, age, hypertension, dyslipidaemia, body mass index, waist circumference, glycated haemoglobin, glucose levels, smoking habit, diabetes duration, antiplatelet use, and alanine aminotransferase levels. Results. A total of 513 subjects (151 T1D, 155 T2D, and 207 non-diabetic control) were included, in whom the percentage with SCA was 48.3%, 49.7%, and 46.9%, respectively. A total of 27 unique lipid species were associated with SCA in subjects with T2D, in former/current smokers with T2D, and in individuals with T2D without dyslipidaemia. Phosphatidylcholines and diacylglycerols were the main SCA-associated lipidic classes. Ten different species of phosphatidylcholines were up-regulated, while 4 phosphatidylcholines containing polyunsaturated fatty acids were down-regulated. One diacylglycerol was down-regulated, while the other 3 were positively associated with SCA in individuals with T2D without dyslipidaemia. We discovered several features significantly associated with SCA in individuals with T1D, but only one sterol could be partially annotated. Conclusions. We revealed a significant disruption of lipid metabolism associated with SCA in subjects with T2D, and a larger SCA-associated disruption in former/current smokers with T2D and individuals with T2D who do not undergo lipid-lowering treatment., This work was funded by Spanish Ministry of Health, Instituto de Salud Carlos III (Madrid, Spain) grants PI15/0625 (to DM and EC), PI17/01362 (to NA), PI18/0328 (to DM), FEDER “Una manera de hacer Europa”, and by Fundació La Marató de TV3 2016 (303/C/2016) (201602.30.31) (to NA). This work was supported by the Grant PID2021-122952OB-I00 funded by AEI https:/ /doi. org/10.13039/501100011033 and by ERDF A way of making Europe (to AP). This research was supported by Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders (CIBERDEM–CB15/00071) (to DM) and Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), initiatives of Instituto de Investigación Carlos III (ISCIII); ISCIII (grant AC22/00035) (to AP); and the CERCA Programme / Generalitat de Catalunya. B2SLab is certified as 2021 SGR 01052. Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau is accredited by the Generalitat de Catalunya as Centre de Recerca de Catalunya (CERCA)., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Personalized air quality monitoring and respiratory health in moderate and severe asthma: findings from a six-month observational study

  • Marín López, Daniel
  • Escalona López, Sergio Vidal
  • Salvador, Rosana Hernando
  • Alfaras Espinàs, Miquel
  • López Giraldo, Alejandra
  • Lores Obradors, Luis
  • Sáez Zamora, José Alberto
  • Fonollosa Magrinyà, Jordi
  • Haddi, Zouhair
Introduction Asthma affects over 339 million people worldwide, contributing substantially to morbidity, reduced quality of life, and premature mortality. Air pollution is a major risk factor, but stationary monitors lack the resolution to capture individual exposure. This study aimed to (i) evaluate the feasibility of integrating personalized air quality monitoring with digital health tools in patients with moderate-to-severe asthma; (ii) explore preliminary associations between pollutant exposures and respiratory outcomes; and (iii) characterize interrelations among symptoms, spirometry, wearable-derived physiology, and inhaler use. Methods: Thirteen adults with moderate-to-severe asthma participated in a six-month observational study using a digital monitoring ecosystem. This combined wearable sensors for physiological and air quality data, daily symptom reporting via smartphone, and spirometry assessments. Outdoor pollution data were obtained from the nearest fixed-site monitoring station. Results: Personal sensors revealed highly variable exposures that diverged from ambient measurements, particularly for nitrogen dioxide, which showed greater variability and more frequent exceedances of World Health Organization thresholds. Self-reported symptoms and inhaler use were strongly correlated. However, no consistent associations were observed between pollution exposure and health outcomes, including symptoms or spirometry results, even when time-lagged effects were considered. Conclusion: These findings highlight the limitations of relying on ambient stations to assess exposure in asthma research and underscore the importance of individualized monitoring. Combining wearable pollution sensors with continuous symptom tracking and remote lung function testing is feasible and patient-centered. This integrative approach may inform precision medicine strategies and improve individualized asthma management., This work was supported by the project A-IQ READY, which is cofunded by the European Union and by the Chips Joint Undertaking and its members under Grant Agreement No 101096658, the Spanish Ministry of Economy and Competitiveness (www.mineco.gob.es) PID2021- 122952OB-I00, Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBERBBN), initiatives of Instituto de Investigación Carlos III (ISCIII), and ISCIII (grant AC22/00035), Pla de Doctorats Industrials de la Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya (2022 DI 014 and 2020 DI 115) and funded by MCIU/AEI/10.13039/501100011033 and European Union (ref PCI2025-163263). We acknowledge CERCA Programme/Generalitat de Catalunya. JF acknowledges the support from the Serra Húnter program. B2SLab is certified as 2021 SGR 01052., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Phenotypic clustering of newly diagnosed type 2 diabetes in a Mediterranean cohort

  • Fernandez-Camins, Berta
  • Vlacho, Bogdan
  • Rojo-López, Marina Idalia
  • Granado-Casas, Minerva
  • Gratacòs, Mònica
  • Ortega-Bravo, Marta
  • Cendros-Massioui, Maria
  • Palmieri, Flavio
  • Perera Lluna, Alexandre
  • Franch-Nadal, Josep
  • Mauricio, Dídac
  • COPERNICAN Research Group, The
© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. Supplementary Information The online version contains supplementary material available at https://doi.org/10.1186/s12933-026-03198-w., Background: Current diagnostic criteria for type 2 diabetes (T2D) capture disease heterogeneity poorly, and do not reliably predict progression, complications, or treatment response. The phenotypic clustering model proposed by Ahlqvist et al. identified five T2D subtypes using six clinical variables at diagnosis, each associated with distinct metabolic profiles and complication risks. Although this framework has been replicated in several cohorts, evidence in Mediterranean populations is lacking. Methods We conducted a prospective cohort study in Catalonia (Northeast Spain) including adults with newly diagnosed T2D recruited between March 2022 and January 2026. Using baseline data, we evaluated the Ahlqvist clustering approach. Autoantibody-positive individuals were classified as severe autoimmune diabetes (SAID), and sex-stratified k-means clustering (k = 4) was applied to autoantibody-negative participants. Cluster separation and stability were assessed using principal component analysis and silhouette analyses. Results A final total number of 991 individuals with newly diagnosed T2D were included in the analysis. Autoantibodies were present in 67 subjects (6.8%), thereby being classified as SAID. Among the remaining 924 participants, sex-stratified k-means clustering (k = 4) identified clusters with metabolic profiles consistent with the classical subtypes: mild age-related diabetes (MARD, n = 326), severe insulin-resistant diabetes (SIRD, n = 241), mild obesity-related diabetes (MOD, n = 206), and severe insulin-deficient diabetes (SIDD, n = 151). However, cluster separation was modest, and bootstrap stability was limited (Jaccard 0.555–0.718). In an unconstrained analysis, apart from the autoimmune diabetes group, silhouette optimisation identified three clusters as the most internally optimal structure, corresponding broadly to obesity/insulin-resistant (C1, n = 347), insulin-deficient (C2, n = 186), and age- related (C3, n = 391) phenotypes. Stability was substantially higher for the three-cluster solution (Jaccard 0.799–0.863). Concordance between the Ahlqvist and data-driven models was moderate (ARI = 0.473), with MOD individuals distributed across the other clusters. Conclusions The Ahlqvist clustering architecture could be approximated in this Mediterranean cohort at diagnosis, but internal stability of the five-cluster solution was limited. In this population, a four-cluster structure showed substantially better internal validity. These findings support the feasibility of phenotypic subclassification of T2D., This research received financial support from the Spanish Ministry of Economy and Competitiveness (www.mineco.gob.es) PID2021-122952OB-I00, DPI2017- 89827-R and Instituto de Salud Carlos III, Ministry of Health (FIS PI21/01163). This work has been financed by a PERIS grant from the Primary Care Oriented Research Projects program with the reference number SLT021/21/000030 granted by the Generalitat de Catalunya (2022–2024). CIBER for Diabetes and Associated Metabolic Diseases (CIBERDEM; leading group CB15/00071) and the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), are initiatives of Instituto de Salud Carlos III (ISCIII). This research was also partially supported by an unrestricted grant from Menarini Group. The sponsor did not have any roles in the study design, collection, analysis, interpretation of data, writing of the report or the decision to submit the article for publication., Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The dilemma of variables assumptions in thermal comfort calculations for educational buildings: to simplify or not?

  • Ruiz de Alegría Sala, Alba
  • Marín López, Daniel
  • Canals Casals, Lluc
  • Fonollosa Magrinyà, Jordi
  • Macarulla Martí, Marcel
Thermal comfort is crucial for people well-being and productivity in buildings, and it has a strong effect on building’s energy usage. The main models for assessing thermal comfort, like predictive mean vote (PMV) and adaptive models, need many environmental measurements, making monitoring complex. That has sparked a debate: some advocate reducing the number of variables, while others stress sticking to the original models. This article evaluates current research trends and addresses the limitations of globe sensors, the most commonly used instrument for measuring mean radiant temperature. To address these is- sues, the study conducts a sensitivity analysis using latin hypercube sampling with multidimen- sional uniformity and employs data from 41 measurements conducted in educational buildings spanning different academic levels, from preschool to university. This analysis examines various simplifications in the measuring procedures for the PMV and adaptive models proposed by ASHRAE 55, ISO 7730 and EN 16798. For this purpose, two mean radiant temperature accuracies are used according to the minimum requirement and the desired value specified by ISO 7726, ±2 ¿C and ±0.2 ¿ C respectively. The results suggest that models with fewer variables tend to overestimate thermal comfort levels. However, this models are valid as their estimations fall within the uncertainty range of the complete model, as long as the mean radiant temperature accuracy is ±2 ¿C as achieved with globe sensors. When mean radiant temperature accuracy improves (i.e. ±0.2 ¿C), the outcome of the models with less variables imply an overestimation falling out of the uncertainty of the complete model., This study is supported by “ComMit-20 – 2020PANDE00116” project funded by L’Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) through the Pandèmies 2020 programme; MOVE4EDU “Modular ventilation system integrated with urban food production in educational buildings" project, reference PID2021-126845OB-C22, funded by MCIN/AEI/10.13039/501100011033 and, by “ ERDF A way of making Europe”; Catalan Agency AGAUR under their research group support program (2021 SGR 00341, 2021 SGR 00226 and 2021 SGR 01052); Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN, Spain), initiatives of Instituto de Investigación Carlos III (ISCIII); ISCIII (grant AC22/00035); ACCI Ó (grant Innotec ACE014/20/000018); the Spanish Ministry of Economy and Competitiveness (www.mineco.gob.es) PID2021- 122952OB-I00; Pla de Doctorats Industrials de la Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya (2022 DI 014); and CERCA Program/Generalitat de Catalunya. JF and LCC also acknowledge the Serra Húnter Program., Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Proof of concept for an age- and inflammation-adjusted model for the establishment of pediatric serum copper reference intervals

  • Rodríguez González, Helena
  • Arias, Ángela
  • Poyatos, Elisabet
  • Mercedes de los Santos, Mariela
  • Minguez, Beatriz
  • Meavilla, Silvia
  • Garcia Volpe, Camila
  • Loverdos, Ines
  • Molera, Cristina
  • Casado Río, Mercedes
  • Ormazábal, Aida
  • Perera Lluna, Alexandre
  • Artuch, Rafael
Background & aims: Copper is a trace element essential for enzymatic reactions, but excessive accumulation can cause toxicity. Accurate interpretation of serum copper concentrations is crucial for diagnosing conditions such as Wilson's disease, liver dysfunction, and nutritional deficiencies. Current reference intervals often ignore the effect of inflammation and are typically established using discrete age groups rather than modelling age as a continuous variable. This study aimed to establish continuous, age-adjusted reference intervals for serum copper and to develop a method for correcting inflammation-related variability. Methods We retrospectively analyzed serum copper concentrations in a pediatric cohort of 4,368 unique samples. Inflammatory status was assessed using erythrocyte sedimentation rate (ESR), fibrinogen, and C-reactive protein (CRP). Samples without inflammation were used to generate age-continuous reference intervals through polynomial regression. To quantify and adjust for inflammation effects, we developed a composite inflammation score using partial least squares regression on standardized values of the three acute-phase markers and applied it to correct copper concentrations in samples exhibiting inflammation. Results Serum copper showed a nonlinear relationship with age. Inflammation elevated copper concentrations by approximately 24 %. The composite inflammation score independently predicted this variability in copper concentrations, and adjustment using the score restored copper concentrations within reference limits, reducing the risk of data misinterpretation. Conclusion Our findings underscore the necessity of considering both age and inflammation variables when interpreting pediatric serum copper concentrations. We provide continuous, age-adjusted reference intervals and a method to correct for inflammation-related variability, enhancing data interpretation. We propose a proof-of-concept potentially applicable to other biomarkers related with metabolic and nutritional disturbances in chronic and acute diseases., This study was supported by Grant PID2021-122952OB-I00 funded by AEI 10.13039/501100011033 and by ERDF, a way of making Europe; the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) initiatives of Instituto de Salud Carlos III (ISCIII); ISCIII (grant AC22/00035); and the CERCA Programme/Generalitat de Catalunya. B2SLab is certified as 2021 SGR 01052. HRG and RA were supported by project Impact Únicas “PMP22/00008”, financed by the ISCIII under the NextGenerationEU Funds of the European Union., Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Home monitoring for older singles: A gas sensor array system

  • Marín López, Daniel
  • Llano Viles, Joshua
  • Haddi, Zouhair
  • Perera Lluna, Alexandre
  • Fonollosa Magrinyà, Jordi
Many residential environments have been equipped with sensing technologies both to provide assistance to older people who have opted for aging-in-place and to provide information to caregivers and family. However, such technologies are often accompanied by physical discomfort, privacy concerns, and complexity of use. We explored the feasibility of monitoring home activity using chemical sensors that pose fewer privacy concerns than, for example, video-cameras and which do not suffer from blind spots. We built a monitoring device that integrates a sensor array and IoT capabilities to gather the necessary data about a resident in his/her living space. Over a period of 3 months, we uninterruptedly measured the living space of a typical elder person living on his/her own. To record the level of activity during the same period and obtain a ground truth for the activity, a set of motion sensors were also deployed in the house. Home activity was extracted from a PCA space moving-window which translated sensor data into the event space; this also compensated for environmental and sensor drift. Our results show that it is possible to monitor the person’s home activity and detect sudden deviations from it using a low-cost, non-invasive, system based on gas sensors that gather data on the air composition in the living space. We made the dataset publicly available at https://archive.ics.uci.edu/ml/index.php2., This work was supported by the Spanish Ministry of Economy and Competitiveness (www.mineco.gob.es) PID2021-122952OB-I00, DPI2017-89827-R, Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), initiatives of Instituto de Investigación Carlos III (ISCIII), Share4Rare project (Grant Agreement 780262), ISCIII (grant AC22/00035), ACCIÓ (grant Innotec ACE014/20/000018) and Pla de Doctorats Industrials de la Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya (2022 DI 014), and the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie (grant No. 101029808). JF also acknowledges the CERCA Program/Generalitat de Catalunya and the Serra Húnter Program. B2SLab is certified as 2017 SGR 952., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Lipidome characterisation and sex-specific differences in type 1 and type 2 diabetes mellitus

  • Barranco Altirriba, María
  • Alonso, Nuria
  • Weber, Ralf
  • Lloyd, Gavin R.
  • Hernández García, Marta
  • Yanes, Óscar
  • Capellades Tomàs, Jordi
  • Jankevics, Andris
  • Winder, Catherine
  • Falguera, Mireia
  • Franch Nadal, Josep
  • Dunn, Warwick B.
  • Perera Lluna, Alexandre
  • Castelblanco, Esmeralda
  • Mauricio Puente, Dídac
Background: In this study, we evaluated the lipidome alterations caused by type 1 diabetes (T1D) and type 2 diabetes (T2D), by determining lipids significantly associated with diabetes overall and in both sexes, and lipids associated with the glycaemic state. Methods: An untargeted lipidomic analysis was performed to measure the lipid profiles of 360 subjects (91 T1D, 91 T2D, 74 with prediabetes and 104 controls (CT)) without cardiovascular and/or chronic kidney disease. Ultra-high performance liquid chromatography-electrospray ionization mass spectrometry (UHPLC-ESI-MS) was conducted in two ion modes (positive and negative). We used multiple linear regression models to (1) assess the association between each lipid feature and each condition, (2) determine sex-specific differences related to diabetes, and (3) identify lipids associated with the glycaemic state by considering the prediabetes stage. The models were adjusted by sex, age, hypertension, dyslipidaemia, body mass index, glucose, smoking, systolic blood pressure, triglycerides, HDL cholesterol, LDL cholesterol, alternate Mediterranean diet score (aMED) and estimated glomerular filtration rate (eGFR); diabetes duration and glycated haemoglobin (HbA1c) were also included in the comparison between T1D and T2D. Results: A total of 54 unique lipid subspecies from 15 unique lipid classes were annotated. Lysophosphatidylcholines (LPC) and ceramides (Cer) showed opposite effects in subjects with T1D and subjects with T2D, LPCs being mainly up-regulated in T1D and down-regulated in T2D, and Cer being up-regulated in T2D and down-regulated in T1D. Also, Phosphatidylcholines were clearly down-regulated in subjects with T1D. Regarding sex-specific differences, ceramides and phosphatidylcholines exhibited important diabetes-associated differences due to sex. Concerning the glycaemic state, we found a gradual increase of a panel of 1-deoxyceramides from normoglycemia to prediabetes to T2D. Conclusions: Our findings revealed an extensive disruption of lipid metabolism in both T1D and T2D. Additionally, we found sex-specific lipidome changes associated with diabetes, and lipids associated with the glycaemic state that can be linked to previously described molecular mechanisms in diabetes., This work was funded by Spanish Ministry of Health, Instituto de Salud Carlos III (Madrid, Spain) grants PI15/0625 (to DM and EC), PI17/01362 (to NA), PI18/0328 (to DM), FEDER “Una manera de hacer Europa”, and by Fundació La Marató de TV3 2016 (303/C/2016) (201602.30.31) (to NA). Spanish Ministry of Economy and Competitiveness, grant PID2021-122952OB-I00 funded by AEI 10.13039/501100011033 and by ERDF A way of making Europe, Instituto de Salud Carlos III (grant AC22/00035); and the CERCA Programme / Generalitat de Catalunya (to AP). This research was supported by CIBER-Consorcio Centro de Investigación Biomèdica en Red-CIBERDEM (leading group CB15/00071) and Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Ministry of Science and Innovation. Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau is accredited by the Generalitat de Catalunya as Centre de Recerca de Catalunya (CERCA). B2SLab is certified as 2021 SGR 01052., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes

  • Barranco-Altirriba, Maria
  • Rossell, Joana
  • Alonso, Núria
  • Weber, Ralf J.M.
  • Ortega, Emilio
  • Lloyd, Gavin R.
  • Hernández García, Marta
  • Yanes, Oscar
  • Capellades, Jordi
  • Winder, Catherine
  • Junza, Alexandra
  • Falguera, Mireia
  • Franch-Nadal, Josep
  • Dunn, Warwick B.
  • Perera-Lluna, Alexandre
  • Castelblanco Echavarría, Esmeralda
  • Mauricio Puente, Dídac
Background. Disruption of lipid metabolism contributes to increased cardiovascular risk in diabetes. Methods. We evaluated the associations between serum lipidomic profile and subclinical carotid atherosclerosis (SCA) in type 1 (T1D) and type 2 (T2D) diabetes, and in subjects without diabetes (controls) in a cross-sectional study. All subjects underwent a lipidomic analysis using ultra-high performance liquid chromatography–electrospray ionization tandem mass spectrometry, carotid ultrasound (mode B) to assess SCA, and clinical assessment. Multiple linear regression models were used to assess the association between features and the presence and burden of SCA in subjects with T1D, T2D, and controls separately. Additionally, multiple linear regression models with interaction terms were employed to determine features significantly associated with SCA within risk groups, including smoking habit, hypertension, dyslipidaemia, antiplatelet use and sex. Depending on the population under study, different confounding factors were considered and adjusted for, including sample origin, sex, age, hypertension, dyslipidaemia, body mass index, waist circumference, glycated haemoglobin, glucose levels, smoking habit, diabetes duration, antiplatelet use, and alanine aminotransferase levels. Results. A total of 513 subjects (151 T1D, 155 T2D, and 207 non-diabetic control) were included, in whom the percentage with SCA was 48.3%, 49.7%, and 46.9%, respectively. A total of 27 unique lipid species were associated with SCA in subjects with T2D, in former/current smokers with T2D, and in individuals with T2D without dyslipidaemia. Phosphatidylcholines and diacylglycerols were the main SCA-associated lipidic classes. Ten different species of phosphatidylcholines were up-regulated, while 4 phosphatidylcholines containing polyunsaturated fatty acids were down-regulated. One diacylglycerol was down-regulated, while the other 3 were positively associated with SCA in individuals with T2D without dyslipidaemia. We discovered several features significantly associated with SCA in individuals with T1D, but only one sterol could be partially annotated. Conclusions. We revealed a significant disruption of lipid metabolism associated with SCA in subjects with T2D, and a larger SCA-associated disruption in former/current smokers with T2D and individuals with T2D who do not undergo lipid-lowering treatment., This work was funded by Spanish Ministry of Health, Instituto de Salud Carlos III (Madrid, Spain) grants PI15/0625 (to DM and EC), PI17/01362 (to NA), PI18/0328 (to DM), FEDER “Una manera de hacer Europa”, and by Fundació La Marató de TV3 2016 (303/C/2016) (201602.30.31) (to NA). This work was supported by the Grant PID2021-122952OB-I00 funded by AEI h t t p s : / / d o i . o r g / 1 0 . 1 3 0 3 9 / 5 0 1 1 0 0 0 1 1 0 3 3 and by ERDF A way of making Europe (to AP). This research was supported by Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders (CIBERDEM–CB15/00071) (to DM) and Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), initiatives of Instituto de Investigación Carlos III (ISCIII); ISCIII (grant AC22/00035) (to AP); and the CERCA Programme / Generalitat de Catalunya. B2SLab is certified as 2021 SGR 01052. Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau is accredited by the Generalitat de Catalunya as Centre de Recerca de Catalunya (CERCA).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Mediterranean Diet Is a Predictor of Progression of Subclinical Atherosclerosis in a Mediterranean Population: The ILERVAS Prospective Cohort Study

  • Rojo López, Marina Idalia
  • Bermúdez López, Marcelino
  • Castro, Eva
  • Farràs, Cristina
  • Torres, Gerard
  • Pamplona Gras, Reinald
  • Lecube Torelló, Albert
  • Valdivieso, José Manuel
  • Fernández, Elvira
  • Julve, Josep
  • Castelblanco Echavarría, Esmeralda
  • Alonso, Núria
  • Antentas, Maria
  • Barranco Altirriba, María
  • Perera-Lluna, Alexandre
  • Franch-Nadal, Josep
  • Granado Casas, Minerva
  • Mauricio Puente, Dídac
  • ILERVAS Project Collaborators
Atherosclerotic cardiovascular disease remains a major health issue, often developing silently as subclinical atherosclerotic disease (SAD). The Mediterranean diet (MDiet) is known for its cardiovascular benefits, but the combined influence of both MDiet adherence and physical activity (PA) on SAD progression has not been previously documented. Objective: We aimed to investigate how adherence to a healthy lifestyle, defined as MDiet adherence and PA level, influences SAD progression in subjects from the ILERVAS cohort follow-up. Methods: A study on 3097 participants from the ILERVAS prospective cohort was conducted. MDiet adherence was assessed using the MEDAS score, and PA categories were established using the IPAQ, both categorized into low, moderate, and high levels. Two different lifestyle scores integrating the MDiet and PA categories were built. The presence of atherosclerotic plaques was assessed by carotid and femoral ultrasound examination. Demographic, clinical, and biochemical data were also obtained. Multivariable linear, logistic, and Poisson regression models adjusted for potential confounders were used to analyze the association between the lifestyle scores and SAD progression, as well as the MDiet and PA as separate variables and number of territories with plaque. Results: A healthier lifestyle score did not show an effect on SAD progression. However, a higher MEDAS score was associated with a 3% decrease in the number of territories with plaque (IRR 0.97, 95% CI 0.96–0.99, p < 0.001), suggesting a protective effect of the adherence to the MDiet. PA did not show a significant association (IRR 1.00, 95% CI 1.00–1.00, p = 0.269). Older age, hypertension, dyslipidemia, smoking, and lower eGFR were associated with SAD progression, while the female sex was protective (IRR 0.67, 95% CI 0.63–0.72, p < 0.001). Conclusions: The findings of this study show that higher adherence to the MDiet is associated with reduced incidence of SAD, indicating its potential role in cardiovascular prevention strategies. Although a higher lifestyle score or physical activity levels did not show any significant effect, promoting the MDiet, alongside managing traditional cardiovascular risk factors, could be an effective public health intervention to prevent atherosclerosis and reduce the burden of cardiovascular disease., This research was supported by the CIBER-Consorcio Centro de Investigación Biomédica en Red-(CB15/00071), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Spain. M.I.R.-L. holds a predoctoral grant SLT017/20/000107 from Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2021–2024 of Generalitat de Catalunya. JJ has received financial support from the Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033 and the European Union “NextGeneration EU”/PRTR) within the action “Consolidación Investigadora 2022” (CNS2022-135559) and Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Madrid, Spain), grant PI21/00770 (to J.J.), FEDER “Una manera de hacer Europa”. M Bermúdez-López holds a postdoctoral grant funded by the Ministerio de Ciencia, Innovación y Universidades (IJC2018-037792-I). This research was also funded by the Ministerio de Ciencia, Innovación y Universidades (grant PID2023-152233OBI00, co-funded by the European Regional Development Fund, “A way to build Europe”), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) and Department of Health (SLT002/16/00250) to R.P. This work was supported by grants from the Diputació de Lleida, Instituto de Salud Carlos III (RETIC RD16/0009/0011). This work was also supported by the Grant PID2021-122952OB-I00 funded by AEI 10.13039/501100011033 and by ERDF A way of making Europe; the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), initiatives of Instituto de Investigación Carlos III (ISCIII); ISCIII (grant AC22/00035); and the CERCA Programme/Generalitat de Catalunya. B2SLab is certified as 2021 SGR 01052. Institut d’Investigació Biomèdica Sant Pau and Biomedical Research Institute’s Dr. Pifarré Foundation from Lleida (IRBLleida) are accredited by the Generalitat de Catalunya as Centre de Recerca de Catalunya (CERCA).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Mediterranean diet is a predictor of progression of subclinical atherosclerosis in a mediterranean population: the ILERVAS prospective cohort study

  • Rojo López, Marina Idalia
  • Bermudez Lopez, Marcelino
  • Castro Boqué, Eva
  • Farràs Sallés, Cristina
  • Torres Cortada, Gerard
  • Pamplona Gras, Reinald
  • Lecube Torelló, Albert
  • Valdivieso Revilla, José Manuel
  • Fernández Giráldez, Elvira
  • Julve Gil, Josep
  • Castelblanco, Esmeralda
  • Alonso Pedrol, Núria
  • Antentas, Maria
  • Barranco Altirriba, María
  • Perera Lluna, Alexandre
  • Franch Nadal, Josep
  • Granado Casas, Minerva
  • Mauricio Puente, Dídac
Atherosclerotic cardiovascular disease remains a major health issue, often developing silently as subclinical atherosclerotic disease (SAD). The Mediterranean diet (MDiet) is known for its cardiovascular benefits, but the combined influence of both MDiet adherence and physical activity (PA) on SAD progression has not been previously documented. Objective: We aimed to investigate how adherence to a healthy lifestyle, defined as MDiet adherence and PA level, influences SAD progression in subjects from the ILERVAS cohort follow-up. Methods: A study on 3097 participants from the ILERVAS prospective cohort was conducted. MDiet adherence was assessed using the MEDAS score, and PA categories were established using the IPAQ, both categorized into low, moderate, and high levels. Two different lifestyle scores integrating the MDiet and PA categories were built. The presence of atherosclerotic plaques was assessed by carotid and femoral ultrasound examination. Demographic, clinical, and biochemical data were also obtained. Multivariable linear, logistic, and Poisson regression models adjusted for potential confounders were used to analyze the association between the lifestyle scores and SAD progression, as well as the MDiet and PA as separate variables and number of territories with plaque. Results: A healthier lifestyle score did not show an effect on SAD progression. However, a higher MEDAS score was associated with a 3% decrease in the number of territories with plaque (IRR 0.97, 95% CI 0.96–0.99, p < 0.001), suggesting a protective effect of the adherence to the MDiet. PA did not show a significant association (IRR 1.00, 95% CI 1.00–1.00, p = 0.269). Older age, hypertension, dyslipidemia, smoking, and lower eGFR were associated with SAD progression, while the female sex was protective (IRR 0.67, 95% CI 0.63–0.72, p < 0.001). Conclusions: The findings of this study show that higher adherence to the MDiet is associated with reduced incidence of SAD, indicating its potential role in cardiovascular prevention strategies. Although a higher lifestyle score or physical activity levels did not show any significant effect, promoting the MDiet, alongside managing traditional cardiovascular risk factors, could be an effective public health intervention to prevent atherosclerosis and reduce the burden of cardiovascular disease., This research was supported by the CIBER-Consorcio Centro de Investigación Biomédica en Red-(CB15/00071), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Spain. M.I.R.-L. holds a predoctoral grant SLT017/20/000107 from Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2021–2024 of Generalitat de Catalunya. JJ has received financial support from the Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033 and the European Union “NextGeneration EU”/PRTR) within the action “Consolidación Investigadora 2022” (CNS2022-135559) and Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Madrid, Spain), grant PI21/00770 (to J.J.), FEDER “Una manera de hacer Europa”. M Bermúdez-López holds a postdoctoral grant funded by the Ministerio de Ciencia, Innovación y Universidades (IJC2018-037792-I). This research was also funded by the Ministerio de Ciencia, Innovación y Universidades (grant PID2023-152233OB-I00, co-funded by the European Regional Development Fund, “A way to build Europe”), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) and Department of Health (SLT002/16/00250) to R.P. This work was supported by grants from the Diputació de Lleida, Instituto de Salud Carlos III (RETIC RD16/0009/0011). This work was also supported by the Grant PID2021-122952OB-I00 funded by AEI 10.13039/501100011033 and by ERDF A way of making Europe; the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), initiatives of Instituto de Investigación Carlos III (ISCIII); ISCIII (grant AC22/00035); and the CERCA Programme/Generalitat de Catalunya. B2SLab is certified as 2021 SGR 01052. Institut d’Investigació Biomèdica Sant Pau and Biomedical Research Institute’s Dr. Pifarré Foundation from Lleida (IRBLleida) are accredited by the Generalitat de Catalunya as Centre de Recerca de Catalunya (CERCA)., Peer Reviewed, Membres del ILERVAS project: Eva Miquel, Marta Ortega, Ferran Barbé, Jessica González, Silvia Barril, Manuel Sánchez-de-la-Torre, Manuel Portero-Otín, Mariona Jové, Marta Hernández, Ferran Rius, Pere Godoy and Montse Martinez-Alonso., Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cerebrospinal amino acid profiling in a large cohort of neuropediatric patients with epilepsy

  • Rodríguez González, Helena
  • Nou Fontanet, Laia
  • Ormazábal, Aida
  • Casado Río, Mercedes
  • Arias, Angela
  • Pias Peleteiro, Leticia
  • Gutierrez, Ana
  • Perera Lluna, Alexandre
  • García Cazorla, Ángeles
  • Fons Escupiñà, Maria Carme
  • Artuch, Rafael
This study addresses challenges in cerebrospinal fluid (CSF) amino acid profiling in pediatric neurological disorders by establishing age-continuous reference intervals. It examines amino acid variations in epilepsy of different etiologies and evaluates the effects of antiseizure medications (ASMs), resolving inconsistencies in previous research. We retrospectively analyzed 410 CSF samples from pediatric patients (201 with epilepsy). Reference intervals were established using linear regression, adjusting for age and sex as confounders. Statistical analysis of age-normalized data included tests to assess the relationship between clinical features and altered or normal amino acid levels, multiple regression models evaluating the effects of ASMs on CSF amino acid levels, and hierarchical clustering for pattern identification. Age significantly influenced CSF amino acid levels, with higher concentrations observed in neonates, except for aspartic acid and arginine. Sex was not a significant predictor. Over 90 % of patients with epilepsy had normal levels for most amino acids, except for glutamine, which was more frequently elevated in epilepsy. Valproate and GABAA receptor agonists were linked to elevated glutamine, while vigabatrin therapy was associated with increased levels of ornithine, leucine, and isoleucine. Hierarchical clustering identified a subcluster with elevated essential amino acid levels, predominantly comprising patients with generalized seizures or status epilepticus. This study establishes new CSF amino acid reference intervals for pediatric patients and finds no significant associations between individual amino acid levels and epilepsy-related clinical features. However, a subgroup with high essential amino acid levels, primarily associated with generalized epilepsy, suggests potential links to generalized epileptogenic discharges and blood–brain barrier disruption., This work was supported by Grant PID2021-122952OB-I00 funded by AEI 10.13039/501100011033 and by ERDF, a way of making Europe; the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) initiatives of Instituto de Salud Carlos III (ISCIII); ISCIII (grant AC22/00035); and the CERCA Programme / Generalitat de Catalunya. B2SLab is certified as 2021 SGR 01052. CF was supported by PI22/01441 from Instituto de Salud Carlos III (ISCIII, Spain). HRG was supported by project Impact Únicas PMP22/00008 funded by, as appropriate, by Instituto de Salud Carlos III (ISCIII) under the “European Union NextGenerationEU/PRTR”., Peer Reviewed, Postprint (published version)
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lipidome characterisation and sex-specific differences in type 1 and type 2 diabetes mellitus

  • Barranco-Altirriba, Maria|||0000-0002-1525-210X
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
  • Weber, Ralf J.M.|||0000-0002-8796-4771
  • Lloyd, Gavin R.|||0000-0001-7989-6695
  • Hernandez, Marta
  • Yanes, Oscar|||0000-0003-3695-7157
  • Capellades, Jordi|||0000-0002-6502-8202
  • Jankevics, Andris|||0000-0003-2095-6846
  • Winder, Catherine|||0000-0002-1648-5255
  • Falguera, Mireia|||0000-0002-7846-8952
  • Franch-Nadal, Josep|||0000-0002-5175-1555
  • Dunn, Warwick B.|||0000-0001-6924-0027
  • Perera Lluna, Alexandre|||0000-0001-6427-851X
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Mauricio, Didac|||0000-0002-2868-0250
Background: In this study, we evaluated the lipidome alterations caused by type 1 diabetes (T1D) and type 2 diabetes (T2D), by determining lipids significantly associated with diabetes overall and in both sexes, and lipids associated with the glycaemic state. Methods: An untargeted lipidomic analysis was performed to measure the lipid profiles of 360 subjects (91 T1D, 91 T2D, 74 with prediabetes and 104 controls (CT)) without cardiovascular and/or chronic kidney disease. Ultra-high performance liquid chromatography-electrospray ionization mass spectrometry (UHPLC-ESI-MS) was conducted in two ion modes (positive and negative). We used multiple linear regression models to (1) assess the association between each lipid feature and each condition, (2) determine sex-specific differences related to diabetes, and (3) identify lipids associated with the glycaemic state by considering the prediabetes stage. The models were adjusted by sex, age, hypertension, dyslipidaemia, body mass index, glucose, smoking, systolic blood pressure, triglycerides, HDL cholesterol, LDL cholesterol, alternate Mediterranean diet score (aMED) and estimated glomerular filtration rate (eGFR); diabetes duration and glycated haemoglobin (HbA1c) were also included in the comparison between T1D and T2D. Results: A total of 54 unique lipid subspecies from 15 unique lipid classes were annotated. Lysophosphatidylcholines (LPC) and ceramides (Cer) showed opposite effects in subjects with T1D and subjects with T2D, LPCs being mainly up-regulated in T1D and down-regulated in T2D, and Cer being up-regulated in T2D and down-regulated in T1D. Also, Phosphatidylcholines were clearly down-regulated in subjects with T1D. Regarding sex-specific differences, ceramides and phosphatidylcholines exhibited important diabetes-associated differences due to sex. Concerning the glycaemic state, we found a gradual increase of a panel of 1-deoxyceramides from normoglycemia to prediabetes to T2D. Conclusions: Our findings revealed an extensive disruption of lipid metabolism in both T1D and T2D. Additionally, we found sex-specific lipidome changes associated with diabetes, and lipids associated with the glycaemic state that can be linked to previously described molecular mechanisms in diabetes.